<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE article PUBLIC "-//NLM//DTD Journal Publishing DTD v2.3 20070202//EN" "journalpublishing.dtd">
<article article-type="review-article" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xml:lang="EN">
<front>
<journal-meta>
<journal-id journal-id-type="publisher-id">Front. Reprod. Health</journal-id>
<journal-title>Frontiers in Reproductive Health</journal-title>
<abbrev-journal-title abbrev-type="pubmed">Front. Reprod. Health</abbrev-journal-title>
<issn pub-type="epub">2673-3153</issn>
<publisher>
<publisher-name>Frontiers Media S.A.</publisher-name>
</publisher>
</journal-meta>
<article-meta>
<article-id pub-id-type="doi">10.3389/frph.2025.1627670</article-id>
<article-categories>
<subj-group subj-group-type="heading">
<subject>Reproductive Health</subject>
<subj-group>
<subject>Review</subject>
</subj-group>
</subj-group>
</article-categories>
<title-group>
<article-title>A sustainable public health framework for PCOS management in low- and middle-income countries: a narrative review</article-title>
</title-group>
<contrib-group>
<contrib contrib-type="author"><name><surname>Vasudevan</surname><given-names>Sudharsan</given-names></name>
<xref ref-type="aff" rid="aff1"><sup>1</sup></xref><uri xlink:href="https://loop.frontiersin.org/people/3197822/overview" /><role content-type="https://credit.niso.org/contributor-roles/conceptualization/"/><role content-type="https://credit.niso.org/contributor-roles/methodology/"/><role content-type="https://credit.niso.org/contributor-roles/writing-original-draft/"/></contrib>
<contrib contrib-type="author"><name><surname>Gautam</surname><given-names>Rohit</given-names></name>
<xref ref-type="aff" rid="aff1"><sup>1</sup></xref><uri xlink:href="https://loop.frontiersin.org/people/3197894/overview" /><role content-type="https://credit.niso.org/contributor-roles/data-curation/"/><role content-type="https://credit.niso.org/contributor-roles/writing-original-draft/"/></contrib>
<contrib contrib-type="author"><name><surname>Maan</surname><given-names>Pratibha</given-names></name>
<xref ref-type="aff" rid="aff1"><sup>1</sup></xref><uri xlink:href="https://loop.frontiersin.org/people/647437/overview" /><role content-type="https://credit.niso.org/contributor-roles/data-curation/"/><role content-type="https://credit.niso.org/contributor-roles/writing-original-draft/"/></contrib>
<contrib contrib-type="author"><name><surname>Arora</surname><given-names>Amit</given-names></name>
<xref ref-type="aff" rid="aff2"><sup>2</sup></xref><role content-type="https://credit.niso.org/contributor-roles/conceptualization/"/><role content-type="https://credit.niso.org/contributor-roles/writing-review-editing/"/></contrib>
<contrib contrib-type="author"><name><surname>Ganie</surname><given-names>Ashraf</given-names></name>
<xref ref-type="aff" rid="aff3"><sup>3</sup></xref><uri xlink:href="https://loop.frontiersin.org/people/577281/overview"/><role content-type="https://credit.niso.org/contributor-roles/conceptualization/"/><role content-type="https://credit.niso.org/contributor-roles/investigation/"/><role content-type="https://credit.niso.org/contributor-roles/writing-review-editing/"/></contrib>
<contrib contrib-type="author" corresp="yes"><name><surname>Jabbar</surname><given-names>Puthiyaveettil Khadar</given-names></name>
<xref ref-type="aff" rid="aff4"><sup>4</sup></xref>
<xref ref-type="corresp" rid="cor1">&#x002A;</xref>
<uri xlink:href="https://loop.frontiersin.org/people/1080558/overview" />
<role content-type="https://credit.niso.org/contributor-roles/supervision/"/><role content-type="https://credit.niso.org/contributor-roles/validation/"/><role content-type="https://credit.niso.org/contributor-roles/writing-review-editing/"/></contrib>
<contrib contrib-type="author" corresp="yes"><name><surname>Arora</surname><given-names>Taruna</given-names></name>
<xref ref-type="aff" rid="aff1"><sup>1</sup></xref>
<xref ref-type="corresp" rid="cor1">&#x002A;</xref><uri xlink:href="https://loop.frontiersin.org/people/2855923/overview" /><role content-type="https://credit.niso.org/contributor-roles/conceptualization/"/><role content-type="https://credit.niso.org/contributor-roles/project-administration/"/><role content-type="https://credit.niso.org/contributor-roles/supervision/"/><role content-type="https://credit.niso.org/contributor-roles/validation/"/><role content-type="https://credit.niso.org/contributor-roles/writing-review-editing/"/></contrib>
</contrib-group>
<aff id="aff1"><label><sup>1</sup></label><institution>Division of RCN, Indian Council of Medical Research</institution>, <addr-line>New Delhi</addr-line>, <country>India</country></aff>
<aff id="aff2"><label><sup>2</sup></label><institution>Sir Ganga Ram Hospital</institution>, <addr-line>New Delhi</addr-line>, <country>India</country></aff>
<aff id="aff3"><label><sup>3</sup></label><institution>Sher-i-Kashmir Institute of Medical Sciences, SKIMS</institution>, <addr-line>Srinagar, Jammu &#x0026; Kashmir</addr-line>, <country>India</country></aff>
<aff id="aff4"><label><sup>4</sup></label><institution>Government Medical College</institution>, <addr-line>Thiruvananthapuram, Kerala</addr-line>, <country>India</country></aff>
<author-notes>
<fn fn-type="edited-by"><p><bold>Edited by:</bold> <ext-link ext-link-type="uri" xlink:href="https://loop.frontiersin.org/people/2712023/overview">Monica Woll Rosen</ext-link>, University of Michigan, United States</p></fn>
<fn fn-type="edited-by"><p><bold>Reviewed by:</bold> <ext-link ext-link-type="uri" xlink:href="https://loop.frontiersin.org/people/1732021/overview">Jim Parker</ext-link>, University of Wollongong, Australia</p>
<p><ext-link ext-link-type="uri" xlink:href="https://loop.frontiersin.org/people/1233389/overview">Daniel Berhanie Enyew</ext-link>, Dan, Ethiopia</p></fn>
<corresp id="cor1"><label>&#x002A;</label><bold>Correspondence:</bold> Puthiyaveettil Khadar Jabbar <email>drjabbar10@gmail.com</email> Taruna Arora <email>tarunakatyal@gmail.com</email></corresp>
</author-notes>
<pub-date pub-type="epub"><day>18</day><month>09</month><year>2025</year></pub-date>
<pub-date pub-type="collection"><year>2025</year></pub-date>
<volume>7</volume><elocation-id>1627670</elocation-id>
<history>
<date date-type="received"><day>13</day><month>05</month><year>2025</year></date>
<date date-type="accepted"><day>28</day><month>08</month><year>2025</year></date>
</history>
<permissions>
<copyright-statement>&#x00A9; 2025 Vasudevan, Gautam, Maan, Arora, Ganie, Jabbar and Arora.</copyright-statement>
<copyright-year>2025</copyright-year><copyright-holder>Vasudevan, Gautam, Maan, Arora, Ganie, Jabbar and Arora</copyright-holder><license license-type="open-access" xlink:href="http://creativecommons.org/licenses/by/4.0/">
<p>This is an open-access article distributed under the terms of the <ext-link ext-link-type="uri" xlink:href="http://creativecommons.org/licenses/by/4.0/">Creative Commons Attribution License (CC BY)</ext-link>. The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.</p></license>
</permissions>
<abstract><sec><title>Background</title>
<p>Polycystic Ovary Syndrome is an endocrine disorder that affects reproductive, metabolic, and mental health. In LMICs, PCOS management is hindered by late diagnosis, lack of awareness, and high treatment costs which leads to long-term complications.</p>
</sec><sec><title>Objective</title>
<p>The aim of the review is to document the challenges in PCOS diagnosis and management in LMICs and provide public health solution to overcome these barriers in accordance with SDG goals.</p>
</sec><sec><title>Methods</title>
<p>A narrative review synthesizing existing literature on PCOS epidemiology, barriers to diagnosis and treatment, and potential solutions relevant to LMICs.</p>
</sec><sec><title>Results</title>
<p>Key challenges include lack of uniformity in diagnosis and treatment, lack of trained HR and equipment. High cost of care, stigma and fragmented health care.</p>
</sec><sec><title>Outcomes/proposed solutions</title>
<p>Develop national PCOS guidelines, bring the management of PCOS under the reproductive health program, shift some of the tasks to primary health workers, like generating awareness and screening for symptoms. Invest in research to find public health solutions.</p>
</sec><sec><title>Conclusion</title>
<p>Addressing PCOS in LMICs requires a multi-sectoral public health approach, including prevention, early detection, and affordable care. Strengthening healthcare systems through policy reforms and community-based interventions can improve outcomes for affected women.</p>
</sec>
</abstract>
<kwd-group>
<kwd>PCOS</kwd>
<kwd>LMICs</kwd>
<kwd>public health</kwd>
<kwd>diagnosis</kwd>
<kwd>treatment</kwd>
<kwd>SDG goals</kwd>
</kwd-group><contract-num rid="cn001">5/7/103/PCOS-phaseII/NTF/2020RBMCH</contract-num><contract-sponsor id="cn001">ICMR (Indian Council of Medical Research)</contract-sponsor><counts>
<fig-count count="3"/>
<table-count count="3"/><equation-count count="0"/><ref-count count="113"/><page-count count="13"/><word-count count="0"/></counts><custom-meta-wrap><custom-meta><meta-name>section-at-acceptance</meta-name><meta-value>Access and Barriers to Reproductive Health Services</meta-value></custom-meta></custom-meta-wrap>
</article-meta>
</front>
<body><sec id="s1" sec-type="background"><label>1</label><title>Background</title>
<p>Polycystic Ovary&#x2002;Syndrome (PCOS) is one of the most common disorders among reproductive-age women worldwide. The Rotterdam criteria defines it as a combination of features like hyperandrogenism, ovulatory dysfunction, and polycystic ovarian morphology (<xref ref-type="bibr" rid="B1">1</xref>). PCOS is characterized by a heterogeneous range of clinical features, including oligomenorrhea, anovulation and infertility on the one end, and metabolic disorders such as hyperinsulinemia, insulin resistance and obesity on the other (<xref ref-type="bibr" rid="B2">2</xref>). These symptoms often overlap with other health conditions, complicating the diagnosis and management of the disorder. Globally, the prevalence of PCOS is estimated to range between 6&#x0025; and 20&#x0025;, depending on the diagnostic criteria and population studied. In India, however, the prevalence is alarmingly high, with reports suggesting rates as high as 36&#x0025; among women of reproductive age (<xref ref-type="bibr" rid="B2">2</xref>). This disparity is often attributed to rapid urbanization, increasing rates of obesity, and lifestyle changes among Indian women. The higher prevalence of PCOS in urban settings compared to rural areas further underscores the role of environmental and lifestyle factors in its pathogenesis (<xref ref-type="bibr" rid="B3">3</xref>). The impact of PCOS extends beyond reproductive health, significantly affecting metabolic and psychological well-being. Women with PCOS are at a higher risk of developing cardiovascular diseases and non-alcoholic fatty liver disease as well (<xref ref-type="bibr" rid="B4">4</xref>). In addition, the psychological burden of PCOS, including increased rates of anxiety, depression, and body image issues, often remains underdiagnosed and untreated (<xref ref-type="bibr" rid="B5">5</xref>). These complications highlight the need for holistic approaches to the diagnosis and management of PCOS, particularly in low-resource settings where healthcare systems are already overburdened.</p>
<p>The complexities involved in the diagnosis and management of PCOS are more pronounced in low&#x2014;resource settings than in developed ones. Low and middle income countries (LMICs) are part of a classification system developed by World bank that classifies based on gross national income capita, where healthcare resources are limited (<xref ref-type="bibr" rid="B6">6</xref>). These countries have issues like poor developed healthcare, insufficiently trained medical personal, higher costs of tests and drugs because of reduced availability (<xref ref-type="bibr" rid="B7">7</xref>). These include problems like lack of recognition of the condition by women and health workers as well as the socio-economic strains and the underdeveloped health care system (<xref ref-type="bibr" rid="B8">8</xref>). It is common to see a late diagnosis of PCOS since many women go to the doctor only when they have infertility or other advanced complications of PCOS (<xref ref-type="bibr" rid="B9">9</xref>). A study in Bangladesh reiterates the problem of delayed diagnosis in PCOS lack of awareness about PCOS among women (<xref ref-type="bibr" rid="B10">10</xref>). Health disparities between urban and rural areas also cause the problem to become more complex. While metropolis may offer women professionals and advanced testing equipment, rural women depend on primary healthcare providers, who may not have the necessary training or resources to diagnose and treat PCOS effectively (<xref ref-type="bibr" rid="B9">9</xref>). A study from Nigeria discusses issues with awareness, and poor health infrastructure affecting PCOS care (<xref ref-type="bibr" rid="B11">11</xref>). This disparity is further exacerbated by social taboos on discussions concerning menstrual and reproductive health, and thus, the society hinders the opportunity for quick medical assistance. One of the socioeconomic aspects also in fact that the cost involved in acquiring these diagnostic tests is one of the major barriers to accessing medical care. The costs of diagnostic tests like hormone assays and ultrasound imaging that are done on the ovary, and which are not covered by insurance, make the tests unaffordable to many in low-income situations (<xref ref-type="bibr" rid="B12">12</xref>&#x2013;<xref ref-type="bibr" rid="B14">14</xref>). Lack of integrated care also affects PCOS management, due to which only selective management of PCOS manifestations gets treated due to their obvious presentation, while long term complications get neglected (<xref ref-type="bibr" rid="B13">13</xref>, <xref ref-type="bibr" rid="B15">15</xref>, <xref ref-type="bibr" rid="B16">16</xref>).</p>
<p>Efforts to address PCOS in these settings require a comprehensive approach that includes preventive measures, early diagnosis, and community-based interventions (<xref ref-type="bibr" rid="B1">1</xref>, <xref ref-type="bibr" rid="B8">8</xref>). Community-based healthcare models have shown promise in bridging the gap between urban and rural healthcare disparities (<xref ref-type="bibr" rid="B17">17</xref>). Telemedicine platforms also offer a viable solution for connecting women in remote areas with specialists, reducing the need for travel and associated costs (<xref ref-type="bibr" rid="B18">18</xref>). The 2015 Sustainable development goals (SDG) 3, 5, 10 talk about achieving health for all, gender equality and reducing barriers to health across for all groups by 2030, PCOS being an illness that disproportionately affects a woman of all ages across the world, needs to be tackled head on to achieve those targets (<xref ref-type="bibr" rid="B7">7</xref>, <xref ref-type="bibr" rid="B8">8</xref>). This review tries to bridge the gaps of clinician led approach to tacking this illness by suggesting public health and policy solutions by highlighting varies models and approaches that have been used across the globe. The aim of the review is to document the challenges in PCOS diagnosis and management in LMICs and provide public health solution to overcome these barriers in accordance with SDG goals.</p>
</sec>
<sec id="s2"><label>2</label><title>Challenges to PCOS management in LMIC</title>
<p>This section describes the various bottle necks that prevent PCOS women of LMICs from getting holistic care, which includes challenges in diagnosis and treatment (<xref ref-type="fig" rid="F1">Figure&#x00A0;1</xref>). Addressing these challenges requires a multifaceted approach. Standardizing diagnostic criteria, improving access to diagnostic tools, training healthcare providers, and integrating multidisciplinary care are critical steps (<xref ref-type="bibr" rid="B19">19</xref>, <xref ref-type="bibr" rid="B20">20</xref>).</p>
<fig id="F1" position="float"><label>Figure 1</label>
<caption><p>Bottlenecks for PCOS management in LMICs.</p></caption>
<graphic mimetype="image" mime-subtype="tiff" xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="frph-07-1627670-g001.tif"><alt-text content-type="machine-generated">Diagram illustrating challenges in managing PCOS in low and middle-income countries (LMIC). Central circle labeled \"Challenge in PCOS management in LMIC\" is surrounded by factors: lack of standardized diagnostic criteria, low adherence to lifestyle changes, mental health challenges, fragmented healthcare systems, high cost of treatment, cultural and societal barriers, and lack of equipment and trained HR.</alt-text>
</graphic>
</fig>
<sec id="s2a"><label>2.1</label><title>Challenges in diagnosis</title>
<sec id="s2a1"><label>2.1.1</label><title>Lack of standardised diagnostic criteria</title>
<p>The absence of uniform diagnostic criteria for PCOS the world is one of the barriers for PCOS diagnosis. The 3 most common guidelines are the 2003 Rotterdam Consensus and the criteria of the National Institutes of Health (NIH) and the Androgen Excess and PCOS Society (AE-PCOS) (<xref ref-type="bibr" rid="B21">21</xref>).</p>
<p>Rotterdam criteria: Claims that two of the following three features should be hyperandrogenism (HA), oligo/anovulation (OA), and polycystic ovarian morphology (PCOM) on ultrasound for a woman to full fill the PCOS classification, while the absence of the remaining feature is being compensated by two other features (<xref ref-type="bibr" rid="B22">22</xref>).</p>
<p>NIH: Specifies that the diagnosis should include hyperandrogenism and oligo/anovulation but exclude the ultrasound findings (<xref ref-type="bibr" rid="B23">23</xref>).</p>
<p>AE-PCOS Criteria: States that women should have hyperandrogenism and at least one other feature to be diagnosed with PCOS (<xref ref-type="bibr" rid="B24">24</xref>).</p>
<p>Due to the variability of the disease, the symptoms of PCOS it is often a matter of controversy among medical practitioners and sometimes the diagnosis is inconsistent especially in primary care settings. Women are often treated without adequate diagnosis which leads to inappropriate treatment. Furthermore, the condition can worsen (<xref ref-type="bibr" rid="B1">1</xref>).</p>
<p>The diagnosis of PCOS is further complicated by varying phenotypic presentations such as phenotype-A which includes all the three criteria for diagnosis, phenotype-B includes hyper androgenic and oligo anovulatory features (HA&#x2009;&#x002B;&#x2009;OA), phenotype-C has features of hyper androgenism and polycystic ovaries (HA&#x2009;&#x002B;&#x2009;PCOM), and phenotype-D (OD&#x2009;&#x002B;&#x2009;PCOM). Phenotype-A is more common in subjects identified in clinical populations, whereas phenotype-C is more common in unselected populations (<xref ref-type="bibr" rid="B22">22</xref>, <xref ref-type="bibr" rid="B25">25</xref>).</p>
<p>In low-resource settings, a simpler diagnostic method based on clinical features like oligomenorrhoea and hirsutism might be a practical alternative to the full Rotterdam criteria. This is particularly true when hormonal tests or pelvic ultrasounds are not possible. These models have been suggested as useful tools for early detection and referral from primary care (<xref ref-type="bibr" rid="B24">24</xref>, <xref ref-type="bibr" rid="B26">26</xref>).</p>
</sec>
<sec id="s2a2"><label>2.1.2</label><title>Lack of equipment and trained human resources (HR)</title>
<p>In rural and poor settings, access to diagnostic tools such as high-resolution ultrasound and hormonal assays is limited and knowledge on how to diagnose and screen this disorder is limited (<xref ref-type="bibr" rid="B27">27</xref>, <xref ref-type="bibr" rid="B28">28</xref>). Polycystic ovarian morphology, a key diagnostic criterion in the Rotterdam guidelines, cannot be assessed without ultrasound imaging, trained health care provides who can perform ultrasounds are limited in primary care set up. Hormonal assays for measuring androgen levels are equally challenging to access due lack of specialised technicians in rural healthcare facilities (<xref ref-type="bibr" rid="B29">29</xref>). As a result, diagnosis in these settings often relies on clinical evaluations, which are insufficiently sensitive (<xref ref-type="bibr" rid="B30">30</xref>).</p>
<p>Symptoms related to puberty like irregular periods, acne, and hirsutism may be misinterpreted as normal development or other health issues. This can lead to delay in the right diagnosis and effective treatment (<xref ref-type="bibr" rid="B30">30</xref>). Therefore, it is more important to recognize Polycystic Ovary Syndrome (PCOS) at an early stage among adolescents (<xref ref-type="bibr" rid="B31">31</xref>, <xref ref-type="bibr" rid="B32">32</xref>). On the other hand, a study in India showed that many adolescent PCOS cases were not diagnosed due to the failure of healthcare providers to identify the vague presentation of the syndrome (<xref ref-type="bibr" rid="B2">2</xref>).</p>
<p>PCOS also has symptoms that are common with other medical conditions entitled, thyroid diseases, hyperprolactinemia, and adrenal hyperplasia (<xref ref-type="bibr" rid="B33">33</xref>, <xref ref-type="bibr" rid="B34">34</xref>). This shared symptom presentation further hinders the diagnosis process (<xref ref-type="bibr" rid="B4">4</xref>).</p>
</sec>
<sec id="s2a3"><label>2.1.3</label><title>Cultural and societal barriers</title>
<p>In many cultures, menstruation and infertility are stigmatized topics<bold>,</bold> discouraging women from seeking medical attention (<xref ref-type="bibr" rid="B31">31</xref>, <xref ref-type="bibr" rid="B33">33</xref>). The stigma surrounding menstrual irregularities leads to delays in diagnosis and treatment, particularly in conservative societies (<xref ref-type="bibr" rid="B33">33</xref>). Additionally, a lack of awareness about PCOS among women themselves compounds the problem, as symptoms are often normalized or ignored (<xref ref-type="bibr" rid="B8">8</xref>). Studies from Myanmar, Nepal and Lebanon talk about disaster scenarios in the region where women hardly have access to menstrual education, or menstrual products (<xref ref-type="bibr" rid="B35">35</xref>, <xref ref-type="bibr" rid="B36">36</xref>).</p>
</sec>
</sec>
<sec id="s2b"><label>2.2</label><title>Challenges in PCOS treatment</title>
<sec id="s2b1"><label>2.2.1</label><title>High cost of treatment</title>
<p>PCOS management often involves a combination of pharmacological and non-pharmacological approaches for several years. Medications like oral contraceptives, metformin, and clomiphene citrate are frequently prescribed in tandem (<xref ref-type="bibr" rid="B37">37</xref>). Long term complications of PCOS also require muti disciplinary specialised care, these services are expensive and often unavailable in low-income settings. Lifestyle modification programs, a cornerstone of PCOS treatment, also require resources such as dieticians and fitness professionals, which are inaccessible to many women (<xref ref-type="bibr" rid="B38">38</xref>). Many LMICs lack universal healthcare, leading to them having to send from their own pockets, this leads to catastrophic expenditure (<xref ref-type="bibr" rid="B39">39</xref>) (<xref ref-type="table" rid="T1">Table&#x00A0;1</xref>).</p>
<table-wrap id="T1" position="float"><label>Table 1</label>
<caption><p>Key diagnostic and treatment challenges of PCOS.</p></caption>
<table frame="hsides" rules="groups">
<colgroup>
<col align="left"/>
<col align="left"/>
<col align="left"/>
</colgroup>
<thead>
<tr>
<th valign="top" align="left">Challenge</th>
<th valign="top" align="center">Description</th>
<th valign="top" align="center">Evidence and references</th>
</tr>
</thead>
<tbody>
<tr>
<td valign="top" align="left">Lack of standardized diagnostic criteria</td>
<td valign="top" align="left">Inconsistent criteria (Rotterdam, NIH, AE-PCOS Society) cause diagnostic variability. Phenotypic differences complicate diagnosis further.</td>
<td valign="top" align="left">Variability of PCOS symptoms and diagnostic criteria leads to inconsistent diagnoses (<xref ref-type="bibr" rid="B23">23</xref>, <xref ref-type="bibr" rid="B40">40</xref>).</td>
</tr>
<tr>
<td valign="top" align="left">Lack of equipment and trained human resources</td>
<td valign="top" align="left">Limited access to ultrasound, hormonal assays, and trained specialists in rural settings results in under diagnosis.</td>
<td valign="top" align="left">Insufficient access to diagnostic tools and clinical knowledge in primary care settings (<xref ref-type="bibr" rid="B25">25</xref>, <xref ref-type="bibr" rid="B30">30</xref>).</td>
</tr>
<tr>
<td valign="top" align="left">Cultural and societal barriers</td>
<td valign="top" align="left">Menstruation and infertility stigma discourage women from seeking care, leading to delays in diagnosis and treatment.</td>
<td valign="top" align="left">Cultural stigmas surrounding menstrual health and infertility in conservative societies delay care-seeking (<xref ref-type="bibr" rid="B31">31</xref>, <xref ref-type="bibr" rid="B33">33</xref>).</td>
</tr>
<tr>
<td valign="top" align="left">High cost of treatment</td>
<td valign="top" align="left">Long-term PCOS management requires medications and lifestyle modifications, which are often inaccessible due to high costs.</td>
<td valign="top" align="left">Out-of-pocket expenses in LMICs can lead to catastrophic expenditure (<xref ref-type="bibr" rid="B7">7</xref>, <xref ref-type="bibr" rid="B39">39</xref>).</td>
</tr>
<tr>
<td valign="top" align="left">Fragmented healthcare systems</td>
<td valign="top" align="left">Lack of multidisciplinary care results in symptom-based treatments, primarily for infertility, with long-term complications overlooked.</td>
<td valign="top" align="left">Short-term treatment goals dominate care due to fragmented systems and lack of follow-up (<xref ref-type="bibr" rid="B41">41</xref>, <xref ref-type="bibr" rid="B42">42</xref>).</td>
</tr>
<tr>
<td valign="top" align="left">Mental health challenges</td>
<td valign="top" align="left">High rates of anxiety, depression, and body image issues are prevalent but rarely addressed in PCOS treatment.</td>
<td valign="top" align="left">Mental health services are often absent or stigmatized in PCOS management, especially in low-resource settings (<xref ref-type="bibr" rid="B43">43</xref>, <xref ref-type="bibr" rid="B44">44</xref>).</td>
</tr>
<tr>
<td valign="top" align="left">Low adherence to lifestyle changes</td>
<td valign="top" align="left">Socioeconomic barriers, cultural factors, and lack of structured programs hinder adherence to lifestyle interventions.</td>
<td valign="top" align="left">Women in rural areas lack safe spaces for physical activity and access to nutritious food (<xref ref-type="bibr" rid="B45">45</xref>, <xref ref-type="bibr" rid="B46">46</xref>).</td>
</tr>
</tbody>
</table>
</table-wrap>
<p>Metformin is one of the most affordable medications for diabetes, PCOS and other metabolic syndrome (<xref ref-type="bibr" rid="B47">47</xref>). It significantly reduces insulin resistance and high androgen levels while improving ovulation (<xref ref-type="bibr" rid="B48">48</xref>). Its availability as a generic drug and low monitoring needs makes it a great choice for health systems in low to middle-income countries.</p>
</sec>
<sec id="s2b2"><label>2.2.2</label><title>Fragmented healthcare systems</title>
<p>The treatment of PCOS requires a team of gynaecologists, endocrinologists, dietitians, and mental health professionals work together, but many a case, these are not available in rural as well as in other low resource settings, the specialists if present tend to work on only one aspect of the syndrome and do not take sufficient care to council with rest of the other specialists to provide comprehensive care (<xref ref-type="bibr" rid="B41">41</xref>). Due to which a symptom-based approach to treatment is followed, catering predominantly to patients with problems like infertility, which is more commonly known and hence the collaborative approach to treatment is not followed (<xref ref-type="bibr" rid="B49">49</xref>).</p>
<p>PCOS is associated with long-term issues such as type 2 diabetes, cardiovascular diseases, and endometrial cancer. Despite this, treatment in many settings remains focused on short-term goals like regulating menstrual cycles or inducing ovulation. Long-term complications are often overlooked, particularly in low-resource settings where regular follow-up and preventive care are unavailable (<xref ref-type="bibr" rid="B1">1</xref>).</p>
</sec>
<sec id="s2b3"><label>2.2.3</label><title>Mental health challenges</title>
<p>Anxiety, depression, and body image issues are prevalent among women with PCOS, with studies indicating significantly higher rates compared to the general population (<xref ref-type="bibr" rid="B50">50</xref>). Despite this, mental health is rarely addressed in PCOS treatment plans, particularly in low-resource settings where psychological services are either unavailable or stigmatized (<xref ref-type="bibr" rid="B43">43</xref>).</p>
</sec>
<sec id="s2b4"><label>2.2.4</label><title>Low adherence to lifestyle changes</title>
<p>Lifestyle modification is a cornerstone of PCOS management, yet adherence remains low due to socioeconomic barriers, lack of support, and cultural factors (<xref ref-type="bibr" rid="B45">45</xref>). For instance, women in rural areas may not have access to safe spaces for physical activity or affordable, nutritious food. Additionally, the absence of structured lifestyle intervention programs in low-resource settings further limits their effectiveness.</p>
<p>Summary of the challenges in PCOS diagnosis and management, in LMIC context, in Nepal, sociocultural norms often discourage adolescent girls from seeking reproductive health care, compounding delays in PCOS diagnosis (<xref ref-type="bibr" rid="B35">35</xref>). In Ethiopia, PCOS is underdiagnosed due to a lack of trained gynaecologists outside urban centers (<xref ref-type="bibr" rid="B23">23</xref>). In Brazil and Mexico, PCOS awareness is significantly lower in rural communities compared to urban counterparts, leading to delayed care and higher disease burden (<xref ref-type="bibr" rid="B9">9</xref>). These insights have been incorporated to demonstrate how public health responses must be tailored to reflect each country&#x0027;s epidemiological profile, service availability, and cultural context.</p>
</sec>
</sec>
</sec>
<sec id="s3"><label>3</label><title>Public health solutions</title>
<p>This section discusses, public health solutions like, prevention and early intervention approaches for PCOS, models of cost-effective care and policy changes (<xref ref-type="fig" rid="F2">Figure&#x00A0;2</xref>).</p>
<fig id="F2" position="float"><label>Figure 2</label>
<caption><p>Framework for comprehensive PCOS management in LMIC.</p></caption>
<graphic mimetype="image" mime-subtype="tiff" xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="frph-07-1627670-g002.tif"><alt-text content-type="machine-generated">Flowchart illustrating the process for reducing the burden of PCOS in LMICs. It begins with awareness and early detection through school-based education and community campaigns, feeding into diagnosis and treatment access, supported by task-shifting, mobile clinics, and digital health tools. Comprehensive healthcare includes integration into health programs and is bolstered by standardized guidelines and multidisciplinary care. Policy advocacy, financial support, subsidies, insurance, and research contribute to reduced PCOS burden, leading to the achievement of SDG goals.</alt-text>
</graphic>
</fig>
<sec id="s3a"><label>3.1</label><title>Prevention and early intervention in PCOS</title>
<p>Promoting lifestyle modifications, implementing early diagnosis and treatment are effective strategies contribute holistic care for those diagnosed with PCOS, consequently healthcare costs can be reduced (<xref ref-type="bibr" rid="B51">51</xref>, <xref ref-type="bibr" rid="B52">52</xref>). Early intervention in PCOS management is crucial to the mitigation of type 2 diabetes, cardiovascular disease, and infertility (<xref ref-type="bibr" rid="B53">53</xref>). Furthermore, achieving these goals will require joint action by governments, healthcare providers, educators, and community leaders (<xref ref-type="bibr" rid="B54">54</xref>). The screening for risk factors will facilitate lifestyle interventions in time, which are more effective when started soon (<xref ref-type="bibr" rid="B55">55</xref>). All three mode of prevention the primary, secondary and tertiary plan an important role in reducing the burden of PCOS and its complications in the community (<xref ref-type="fig" rid="F3">Figure&#x00A0;3</xref>).</p>
<fig id="F3" position="float"><label>Figure 3</label>
<caption><p>Prevention and early intervention framework for PCOS care in LMIC.</p></caption>
<graphic mimetype="image" mime-subtype="tiff" xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="frph-07-1627670-g003.tif"><alt-text content-type="machine-generated">Flowchart depicting Prevention and early intervention framework for PCOS care in LMIC. School and community campaigns lead to awareness and education, feeding into early screening and diagnosis. Screening for risk factors and biomarker-based diagnosis in adolescence are connected to early screening. Stress reduction and lifestyle interventions, enhanced by behavioral modification, contribute to prevention and early intervention. Rural outreach directly connects to prevention efforts.</alt-text>
</graphic>
</fig>
<sec id="s3a1"><label>3.1.1</label><title>Early screening and diagnosis</title>
<p>The timely detection of PCOS is important (<xref ref-type="bibr" rid="B56">56</xref>). The period of adolescence is the golden time when it comes to the detection of the earliest symptoms of PCOS that are mostly related to menstrual disturbance, acne, and facial hair (<xref ref-type="bibr" rid="B55">55</xref>, <xref ref-type="bibr" rid="B57">57</xref>). Another intervention that can assist in reaching more people in the community is through the engagement of local leaders and organizations. The roll out of mobile health units with primary diagnostic tools means the screening service can be brought to remote areas and the barriers of geography and finance can be overcome. Biomarkers such as AMH, INH-A, and INSL3 are found to be useful in some studies in the early diagnosis of PCOS in adolescents, there is currently no consensus on their diagnostic thresholds (<xref ref-type="bibr" rid="B58">58</xref>).</p>
</sec>
<sec id="s3a2"><label>3.1.2</label><title>School-based preventive approaches</title>
<p>Educating adolescent girls about menstrual health and the risk factors of PCOS is a cost-effective strategy for recognition of risk factors related to PCOS and encouraging healthy behaviours (<xref ref-type="bibr" rid="B59">59</xref>). School-based programs can include workshops and sessions that normalize discussions about menstrual health can help dispel myths and reduce stigma (<xref ref-type="bibr" rid="B25">25</xref>). Educating young women can emphasize the importance of a balanced diet, regular exercise, and stress management. Incorporating these evidence-based practices into school curricula ensures that students receive consistent support mitigate lifestyle diseases like PCOS (<xref ref-type="bibr" rid="B12">12</xref>). Parents and teachers often play a crucial role in supporting the children, hence sensitizing them is also important for the sustainability of primary prevention strategies (<xref ref-type="bibr" rid="B35">35</xref>).</p>
</sec>
<sec id="s3a3"><label>3.1.3</label><title>Early interventions</title>
<p>Lifestyle interventions like exercise and dietary modification, is an important cornerstone of PCOS prevention and management (<xref ref-type="bibr" rid="B55">55</xref>, <xref ref-type="bibr" rid="B56">56</xref>). Evidence showcases the important role of dietary changes, regular physical activity, and stress management in alleviating symptoms and reducing the risk of complications (<xref ref-type="bibr" rid="B60">60</xref>). Nutritional interventions are important in managing insulin resistance, a common feature of PCOS. Diets rich in whole grains, lean proteins, and vegetables, along with reduced intake of processed foods and sugary beverages, have been shown to improve metabolic and reproductive outcomes (<xref ref-type="bibr" rid="B61">61</xref>). However, implementing such dietary changes can be challenging in low-resource settings due to food insecurity and limited access to nutritional counselling (<xref ref-type="bibr" rid="B62">62</xref>).</p>
<p>Regular exercise has been proven to improve insulin sensitivity, reduce androgen levels, and promote weight loss in women with PCOS. Even moderate-intensity activities, such as brisk walking or yoga, can yield significant benefits (<xref ref-type="bibr" rid="B63">63</xref>). Community-based initiatives that create safe spaces for exercise and promote group activities can help overcome barriers to physical activity in rural areas (<xref ref-type="bibr" rid="B24">24</xref>).</p>
<p>Chronic stress exacerbates PCOS symptoms by disrupting hormonal balance. Stress-reduction techniques, such as mindfulness, meditation, and cognitive-behavioural therapy, are effective in improving mental health and overall quality of life (<xref ref-type="bibr" rid="B64">64</xref>). Integrating these practices into community programs can make stress management accessible to women in low-resource settings.</p>
<p>In low-resource settings, dietary change programs can be supported by school-based initiatives, women-led self-help groups, and nutritional counselling included in primary healthcare systems. In India, similar models have shown success in tackling child and maternal under nutrition (<xref ref-type="bibr" rid="B65">65</xref>&#x2013;<xref ref-type="bibr" rid="B67">67</xref>).</p>
</sec>
</sec>
<sec id="s3b"><label>3.2</label><title>Cost-effective models of care for tackling PCOS</title>
<sec id="s3b1"><label>3.2.1</label><title>Task-shifting models</title>
<p>Task-shifting models represent a strategy of redistributing responsibilities from specialists to trained nurses and primary care physicians (<xref ref-type="bibr" rid="B68">68</xref>). These models can play an important role in improving accessibility to PCOS management (<xref ref-type="bibr" rid="B43">43</xref>). Such methods have the potential to reduce the burden placed on specialists by giving primary care providers the knowledge they need to diagnose and manage PCOS effectively (<xref ref-type="bibr" rid="B69">69</xref>). Training courses aimed at nurses and primary care physicians consist of identifying main symptoms including the irregular menstruation, hyperandrogenism, and polycystic ovarian morphology, as well as offering lifestyle interventions and pharmacological treatments (<xref ref-type="bibr" rid="B70">70</xref>) (<xref ref-type="table" rid="T2">Table&#x00A0;2</xref> and <xref ref-type="fig" rid="F3">Figure&#x00A0;3</xref>).</p>
<table-wrap id="T2" position="float"><label>Table 2</label>
<caption><p>Cost effective models of care in PCOS.</p></caption>
<table frame="hsides" rules="groups">
<colgroup>
<col align="left"/>
<col align="left"/>
<col align="left"/>
</colgroup>
<thead>
<tr>
<th valign="top" align="left">Intervention</th>
<th valign="top" align="center">Description</th>
<th valign="top" align="center">Evidence and references</th>
</tr>
</thead>
<tbody>
<tr>
<td valign="top" align="left" rowspan="2">Task-shifting models</td>
<td valign="top" align="left">Redistributing responsibilities from specialists to trained nurses, primary care physicians, and community health workers (CHWs).</td>
<td valign="top" align="left">Successful in South Africa (NCD care), HIV care models, CHW-led healthcare in India (<xref ref-type="bibr" rid="B71">71</xref>).</td>
</tr>
<tr>
<td valign="top" align="left">Includes early identification, lifestyle interventions, and follow-up for metabolic disorders.</td>
<td valign="top" align="left">Empowering CHWs with portable diagnostic tools improves adherence and follow-up (<xref ref-type="bibr" rid="B72">72</xref>, <xref ref-type="bibr" rid="B73">73</xref>)</td>
</tr>
<tr>
<td valign="top" align="left" rowspan="2">Digital health in primary care</td>
<td valign="top" align="left">Telemedicine provides virtual consultations, reducing travel costs and improving access for rural populations.</td>
<td valign="top" align="left">Mobile health applications improve adherence to lifestyle changes and medication digital risk profiling (<xref ref-type="bibr" rid="B74">74</xref>).</td>
</tr>
<tr>
<td valign="top" align="left">Enables primary care physicians to consult specialists remotely for diagnosis and treatment adjustments.</td>
<td valign="top" align="left">Digital health use in cardiovascular risk profiling and personalized care in New Zealand (<xref ref-type="bibr" rid="B9">9</xref>, <xref ref-type="bibr" rid="B75">75</xref>).</td>
</tr>
<tr>
<td valign="top" align="left" rowspan="2">Community mobilization</td>
<td valign="top" align="left">Mass campaigns raise awareness about PCOS symptoms and promote early diagnosis and health-seeking behavior.</td>
<td valign="top" align="left">Campaigns leveraging radio, TV, social media, and events reduce stigma and encourage preventive care (<xref ref-type="bibr" rid="B76">76</xref>).</td>
</tr>
<tr>
<td valign="top" align="left">Collaborative programs with schools, workplaces, and community groups enhance early recognition and support systems.</td>
<td valign="top" align="left">Workshops for adolescents and male engagement help foster supportive (<xref ref-type="bibr" rid="B77">77</xref>).</td>
</tr>
</tbody>
</table>
</table-wrap>
<p>Adding task-shifting models can also result in earlier diagnosis and management, thus preventing such long-term complications as infertility, type 2 diabetes, and cardiovascular disease (<xref ref-type="bibr" rid="B69">69</xref>). Of note, care to guarantee geographical and economic access is also obtained by these models, and thereby it enables PCOS management to be brought within reach of women in rural and the most underserved regions (<xref ref-type="bibr" rid="B50">50</xref>). The implementation plan consists of rigorous training programs, regular supervision, and the embedding of evidence-based guidelines into primary care settings (<xref ref-type="bibr" rid="B70">70</xref>).</p>
<p>Successful case studies of utilization of task shifting models for non-communicable disease care has been reported in South Africa. Where screening for hypertension which was traditionally done by physician were reallocated to physician assistants (<xref ref-type="bibr" rid="B78">78</xref>). Similar examples have also reported in HIV care, where nurses took over the roles traditionally done by physicians (<xref ref-type="bibr" rid="B79">79</xref>).</p>
<p>Community health workers (CHWs) have long been instrumental in delivering primary healthcare services in underserved regions (<xref ref-type="bibr" rid="B80">80</xref>). The potential of CHWs Like CHOs, MPWs, ANM to bridge gaps in PCOS care by leveraging their trusted position within communities is promising and has been proven effective in other health programs in India (<xref ref-type="bibr" rid="B81">81</xref>, <xref ref-type="bibr" rid="B82">82</xref>)Empowering CHWs with portable diagnostic tools, such as glucometers and blood pressure monitors, they can assist in the early identification, health education and follow up of associated metabolic disorders, thereby improving treatment adherence (<xref ref-type="bibr" rid="B78">78</xref>, <xref ref-type="bibr" rid="B49">49</xref>). Such initiatives require comprehensive training modules, adequate remuneration, and support systems to maintain CHW motivation and effectiveness (<xref ref-type="bibr" rid="B79">79</xref>).</p>
<p>The cost-effectiveness of these three approaches, task-shifting to primary care physicians, structured training for nurses, and CHW-led interventions, has been clearly shown in LMIC health systems. In Uganda, training nurses to conduct cardiovascular and metabolic risk screening cut per-patient costs by 30&#x0025; compared to physician-led services, without affecting diagnostic accuracy (<xref ref-type="bibr" rid="B83">83</xref>). In Tanzania, shifting PMTCT (Prevention of Mother-to-Child Transmission) tasks to nurses and midwives reduced nurse-to-patient time by 25&#x0025; and brought notable cost savings for the health system (<xref ref-type="bibr" rid="B84">84</xref>). CHW-based hypertension management programs in Cameroon demonstrated that giving CHWs portable diagnostic devices and referral protocols was both cost-effective and sustainable. This approach lowered uncontrolled hypertension prevalence at a cost of less than USD 3 per patient each year (<xref ref-type="bibr" rid="B85">85</xref>). These findings highlight that when such models include structured supervision, evidence-based protocols, and performance-linked incentives, they can provide high-quality, affordable PCOS-related services in resource-limited settings.</p>
<p>Simple body measurements such as waist-to-hip ratio (WHR) and waist-to-height ratio (WHtR) strongly relate to insulin resistance and metabolic syndrome in PCOS. They offer a practical, low-cost option for early risk assessment in field situations (<xref ref-type="bibr" rid="B86">86</xref>).</p>
</sec>
<sec id="s3b2"><label>3.2.2</label><title>Digital health in primary care</title>
<p>Advancement in technology even brought telemedicine which is a game changer in the way we should approach PCOS care for those women who live in the countryside and accessible areas of the country (<xref ref-type="bibr" rid="B87">87</xref>). Telemedicine is the provider&#x0027;s vehicle to the patients through virtual check-ups, which in return decrease the need for travel and lessen the costs (<xref ref-type="bibr" rid="B88">88</xref>).</p>
<p>Moreover, telemedicine assists patients&#x2019; interaction through educating materials and guiding on the modification of their lifestyles according to their needs (<xref ref-type="bibr" rid="B52">52</xref>). Telemedicine would enrich an already established healthcare infrastructure by combining a primary care provider with specialists. For instance, general practitioners can communicate with endocrinologists or gynaecologists virtually for confirmations of diagnoses, or treatments refinements (<xref ref-type="bibr" rid="B88">88</xref>). The main advantage of telemedicine is its capability carter to a larger population of the people without a need to correspondingly to increase the workforce. But problems such as digital literacy, internet connection, and data protection concerns must be resolved in the desire to realize equality of access and usage (<xref ref-type="bibr" rid="B53">53</xref>).</p>
<p>Studies in Asia has shown that the use of mobile application in helping improve patient adherence to lifestyle intervention in NCD care. A study in New Zealand has showcased the use of digital health in risk profiling in cardiovascular illness, using real time data, which helps make personalised treatment strategies and improve health outcomes (<xref ref-type="bibr" rid="B89">89</xref>). A study has found that use of remainders telephone messages improve adherence to medications (<xref ref-type="bibr" rid="B90">90</xref>).</p>
<p>New Zealand&#x0027;s CONNECT trial showcased the viability of app-based follow-ups and health coaching for chronic conditions, which includes work with metabolic disorders (<xref ref-type="bibr" rid="B75">75</xref>). In the same vein, India&#x0027;s e-Sanjeevani platform has expanded the delivery of digital health services to rural primary health centres (PHCs). Nevertheless, digital literacy and infrastructural gaps need to be bridged (<xref ref-type="bibr" rid="B87">87</xref>). In Pakistan, a mobile health intervention focused on reproductive disorders improved symptom tracking and adherence to follow-up (<xref ref-type="bibr" rid="B74">74</xref>). Brazil&#x0027;s &#x201C;Telessa&#x00FA;de&#x201D; program, designed for remote consultation and education, demonstrated high user satisfaction among women with hormonal disorders, including PCOS (<xref ref-type="bibr" rid="B88">88</xref>). India&#x0027;s e-Sanjeevani telemedicine platform has successfully delivered NCD and reproductive health consultations across rural and urban areas, including states with limited specialist availability (<xref ref-type="bibr" rid="B91">91</xref>, <xref ref-type="bibr" rid="B92">92</xref>). We have also acknowledged critical barriers such as low digital literacy, inconsistent internet access, and privacy concerns, which could hinder PCOS-specific digital health interventions in LMICs unless addressed through supportive infrastructure and training (<xref ref-type="bibr" rid="B93">93</xref>).</p>
</sec>
<sec id="s3b3"><label>3.2.3</label><title>Community mobilization</title>
<p>Raising awareness about PCOS through mass campaigns is essential to reduce stigma, encourage early diagnosis, and promote health-seeking behaviour (<xref ref-type="bibr" rid="B94">94</xref>). It is also important to use culturally sensitive materials and local languages to engage diverse populations effectively. Awareness campaigns can address misconceptions about PCOS, highlight its symptoms, and educate women about the benefits of timely intervention (<xref ref-type="bibr" rid="B8">8</xref>).</p>
<p>Such campaigns can leverage various media, including radio, television, social media, and community events, to disseminate information (<xref ref-type="bibr" rid="B61">61</xref>). Collaborations with schools, workplaces, and community organizations can amplify the reach and impact of these efforts. For example, organizing workshops and seminars targeting adolescent girls and young women can foster early recognition of symptoms and encourage preventive measures. Additionally, involving male family members in awareness programs can help build supportive environments for women seeking care (<xref ref-type="bibr" rid="B62">62</xref>).</p>
<p>Mass campaigns also play a pivotal role in advocating for policy changes and increasing public investment in PCOS care. By generating widespread awareness and demand for services, these initiatives can drive the expansion of healthcare infrastructure and resources dedicated to PCOS management (<xref ref-type="bibr" rid="B1">1</xref>). However, sustained funding and strategic planning are critical to ensuring the long-term success of awareness campaigns (<xref ref-type="bibr" rid="B63">63</xref>).</p>
</sec>
</sec>
<sec id="s3c"><label>3.3</label><title>Public health policy needs for PCOS management</title>
<sec id="s3c1"><label>3.3.1</label><title>Integration into reproductive health programs</title>
<p>Embedding PCOS diagnosis and management into existing reproductive and maternal health programs can optimize resource utilization and improve accessibility. Training and incentivising existing public health human resources like PHC medical officers, Accredited Social Health Activists (ASHAs) and Auxiliary Nurse Midwives (ANMs) to screen for PCOS symptoms and provide basic counselling can be a cost-effective solution (<xref ref-type="bibr" rid="B95">95</xref>, <xref ref-type="bibr" rid="B96">96</xref>). This approach leverages existing healthcare infrastructure, particularly in rural areas, to identify women at risk and provide timely interventions. US veteran affairs have incorporated PCOS into their program, they have trained their primary health care professionals to diagnose and treat minor manifestations of PCOS. Addressing PCOS requires collaborative efforts involving government agencies, non-governmental organizations (NGOs), and private healthcare providers (<xref ref-type="bibr" rid="B64">64</xref>). Multi-sectoral partnerships enhance the reach and efficacy of PCOS management programs (<xref ref-type="bibr" rid="B97">97</xref>).</p>
<p>Integrating chronic disease management into reproductive health services has shown clear success in low- and middle-income countries and sets a strong example for managing PCOS. In Tanzania, including hypertension and diabetes screening in HIV and antenatal clinics cut patient travel time by 40&#x0025; and increased detection rates for non-communicable diseases without needing additional staff (<xref ref-type="bibr" rid="B98">98</xref>). In Bangladesh, reproductive health workers trained to provide combined maternal health and non-communicable disease services saw a 25&#x0025; rise in early diagnosis of metabolic disorders among women of reproductive age (<xref ref-type="bibr" rid="B99">99</xref>).</p>
</sec>
<sec id="s3c2"><label>3.3.2</label><title>National guidelines for PCOS management</title>
<p>The establishment of standardized national guidelines tailored to low-resource settings is essential for consistent and effective PCOS management (<xref ref-type="bibr" rid="B100">100</xref>). A simplified diagnostic criteria and accessible treatment protocols, including lifestyle interventions and affordable pharmacological options. Although international guidelines are available, national guidelines are realistic, culturally sensitive and should prioritise the unique challenges faced by underserved populations, such as limited access to healthcare and financial constraints (<xref ref-type="bibr" rid="B100">100</xref>) Australia&#x0027;s National Health and Medical Research Council, has developed a guideline for comprehensive management of PCOS (<xref ref-type="bibr" rid="B101">101</xref>).</p>
<p>Nationally adapted guidelines for chronic disease care in low- and middle-income countries show that standardization can improve consistency and quality in settings with limited resources. In South Africa, the Primary Care 101 guideline incorporates algorithms for non-communicable diseases into primary health care practice (<xref ref-type="bibr" rid="B102">102</xref>). This allows nurses to start evidence-based management with little input from specialists, resulting in better adherence to clinical protocols and fewer inappropriate referrals. In India, the NPCDCS program standardizes the management of hypertension and diabetes across states with simple flowcharts and training modules for non-specialist providers (<xref ref-type="bibr" rid="B103">103</xref>). Adapting PCOS guidelines at the country level, with straightforward diagnostic criteria and culturally relevant lifestyle recommendations, would increase feasibility in resource-limited environments.</p>
</sec>
<sec id="s3c3"><label>3.3.3</label><title>Subsidized healthcare services</title>
<p>Subsidizing diagnostic tests, medications, awareness generation through mass campaigns and lifestyle counselling can alleviate the financial burden of PCOS management for low-income populations (<xref ref-type="bibr" rid="B56">56</xref>, <xref ref-type="bibr" rid="B104">104</xref>, <xref ref-type="bibr" rid="B105">105</xref>). The policy interventions that make essential healthcare services more affordable and accessible. Providing incentives to private healthcare providers to offer low-cost services can further expand the availability of care (<xref ref-type="bibr" rid="B50">50</xref>). Subsidized programs can ensure that economic constraints do not hinder women from seeking timely diagnosis and treatment, ultimately improving health outcomes at the population level (<xref ref-type="bibr" rid="B57">57</xref>). In countries like Canada, the provincial health insurance plans cover consultations, diagnostic tests, and treatments of PCOS management.</p>
<p>In Kenya, government-funded non-communicable disease clinics offer free screening for diabetes and hypertension, reducing out-of-pocket costs and improving follow-up (<xref ref-type="bibr" rid="B99">99</xref>). In Sri Lanka, essential medicines for non-communicable diseases are fully subsidized through the public health system, with free metabolic screening available in government hospitals (<xref ref-type="bibr" rid="B15">15</xref>). Applying this model to PCOS could include subsidizing hormone tests, ultrasound imaging, and metformin, along with community-based lifestyle counselling, to reduce financial barriers for low-income women.</p>
</sec>
<sec id="s3c4"><label>3.3.4</label><title>Multi-disciplinary care</title>
<p>PCOS being a muti faceted causes manifestations like the reproductive, metabolic, dermatological and psychological. These might require care from various specialists like obstetricians, endocrinologists, dermatologists and psychiatrist for comprehensive care. Centres like University of California, San Francisco, National institute for research in reproductive health conduct multi-disciplinary clinics to treat PCOS cases (<xref ref-type="bibr" rid="B16">16</xref>, <xref ref-type="bibr" rid="B64">64</xref>). There should be a policy to develop infrastructure for multi-disciplinary clinics all tertiary care hospitals across LMICs.</p>
<p>In South Africa, multidisciplinary NCD clinics bring together reproductive, metabolic, and mental health services in one place. This setup lowers patient drop-out rates and helps people stick to lifestyle changes (<xref ref-type="bibr" rid="B13">13</xref>). In Brazil, the Family Health Strategy connects community health workers with specialists. This approach ensures ongoing support and early treatment for women with reproductive and metabolic issues (<xref ref-type="bibr" rid="B14">14</xref>). These models show that even in areas with limited resources, teamwork among different specialties, backed by referral networks and shared care plans, can lead to better results for PCOS while making the most of available specialist resources.</p>
</sec>
</sec>
<sec id="s3d"><label>3.4</label><title>Research priorities for comprehensive management of PCOS</title>
<sec id="s3d1"><label>3.4.1</label><title>Epidemiological studies</title>
<p>Large-scale epidemiological studies are crucial to understanding the true prevalence and phenotypic variations of PCOS in India (<xref ref-type="bibr" rid="B106">106</xref>). There is a need for comprehensive research that includes both rural and urban populations, providing insights into the disease burden and its socio-demographic correlates. Such studies can inform public health policies and resource allocation, ensuring that interventions are tailored to the needs of diverse populations (<xref ref-type="bibr" rid="B3">3</xref>) (<xref ref-type="table" rid="T3">Table&#x00A0;3</xref>).</p>
<table-wrap id="T3" position="float"><label>Table 3</label>
<caption><p>Research priorities for comprehensive management of PCOS.</p></caption>
<table frame="hsides" rules="groups">
<colgroup>
<col align="left"/>
<col align="left"/>
<col align="left"/>
</colgroup>
<thead>
<tr>
<th valign="top" align="left">Research area</th>
<th valign="top" align="center">Description</th>
<th valign="top" align="center">Evidence and references</th>
</tr>
</thead>
<tbody>
<tr>
<td valign="top" align="left">Epidemiological studies</td>
<td valign="top" align="left">Large-scale studies to find the prevalence and phenotypic variations of PCOS in diverse populations.</td>
<td valign="top" align="center">(<xref ref-type="bibr" rid="B2">2</xref>)</td>
</tr>
<tr>
<td valign="top" align="left">Cost-effective diagnostic tools</td>
<td valign="top" align="left">Developing simplified ultrasound protocols and low-cost biomarker tests to improve accessibility.</td>
<td valign="top" align="center">(<xref ref-type="bibr" rid="B107">107</xref>)</td>
</tr>
<tr>
<td valign="top" align="left">Role of community, culture, and economics</td>
<td valign="top" align="left">Community-based lifestyle programs leveraging local resources for sustainable interventions.</td>
<td valign="top" align="center">(<xref ref-type="bibr" rid="B108">108</xref>)</td>
</tr>
<tr>
<td valign="top" align="left">Implementation research</td>
<td valign="top" align="left">Evaluating training programs for primary healthcare workers and integrating digital health solutions.</td>
<td valign="top" align="center">(<xref ref-type="bibr" rid="B8">8</xref>)</td>
</tr>
<tr>
<td valign="top" align="left">Screening and surveillance</td>
<td valign="top" align="left">Developing and validating surveillance tools for early PCOS detection and monitoring high-risk groups.</td>
<td valign="top" align="center">(<xref ref-type="bibr" rid="B109">109</xref>)</td>
</tr>
</tbody>
</table>
</table-wrap>
</sec>
<sec id="s3d2"><label>3.4.2</label><title>Cost-effective diagnostic tools development</title>
<p>Developing low-cost diagnostic tools, such as simplified ultrasound protocols or biomarker-based tests, can significantly improve accessibility in resource-constrained settings (<xref ref-type="bibr" rid="B110">110</xref>). Affordable one prick diagnostic tools are particularly important in rural areas, where access to advanced healthcare facilities is often limited (<xref ref-type="bibr" rid="B17">17</xref>) (<xref ref-type="table" rid="T3">Table&#x00A0;3</xref>). More affordable markers of insulin resistance and hepatic steatosis in PCOS, such as the triglyceride-glucose index, TG/HDL ratio, HOMA-IR, and ALT/AST ratio, have been validated in numerous LMIC populations (<xref ref-type="bibr" rid="B107">107</xref>).</p>
</sec>
<sec id="s3d3"><label>3.4.3</label><title>Role of community, culture and economics</title>
<p>Pilot studies evaluating community-based lifestyle intervention programs can provide evidence for scalable solutions to PCOS management (<xref ref-type="bibr" rid="B55">55</xref>). Community, school and workplace-based approaches are effective for helping sustain dietary modifications, exercise regimens, and mental health counselling in improving metabolic and reproductive outcomes. Community-based interventions leverage local resources and social networks, making them cost-effective and culturally appropriate (<xref ref-type="bibr" rid="B59">59</xref>).</p>
<p>Research exploring the cultural and socioeconomic determinants of PCOS can inform the development of targeted interventions (<xref ref-type="bibr" rid="B58">58</xref>). The importance of understanding barriers to healthcare access and adherence in different communities. Addressing these factors can enhance the acceptability and effectiveness of public health programs, ensuring that they meet the unique needs of diverse populations (<xref ref-type="bibr" rid="B51">51</xref>).</p>
</sec>
<sec id="s3d4"><label>3.4.4</label><title>Implementation research</title>
<p>Implementation research is critical to integrating PCOS management into existing healthcare systems. There is a need to evaluate training programs for primary healthcare providers and community health workers and assessing effectiveness of improving delivery of these using CHWs lead community-based interventions (<xref ref-type="bibr" rid="B54">54</xref>).</p>
<p>The role of digital health tools, such as mobile apps for symptom tracking and telemedicine for remote consultations, should be explored as cost-effective alternatives for PCOS management (<xref ref-type="bibr" rid="B68">68</xref>). The digital platforms can enhance access to care, particularly in remote and underserved areas. These tools also promote patient engagement and self-management, empowering women to take an active role in their health (<xref ref-type="bibr" rid="B64">64</xref>).</p>
</sec>
<sec id="s3d5"><label>3.4.5</label><title>Screening and surveillance</title>
<p>Screening and surveillance strategies and tools can help in early detection of PCOS risk factors and symptoms among adolescents and young women, studies can be made on developing and validating such surveillance tools and algorithms (<xref ref-type="bibr" rid="B111">111</xref>, <xref ref-type="bibr" rid="B112">112</xref>). Sentinel surveillance sites can be developed at facilities where people with high PCOS risk show up regularly to monitor the trends of the risks, disease and its complications among the target group.</p>
</sec>
</sec>
</sec>
<sec id="s4" sec-type="conclusions"><label>4</label><title>Conclusion</title>
<p>To improve PCOS management in low resource setting where there is inadequate availability of trained health professionals, certain components of it can be merged into primary healthcare systems to improve early identification and comprehensive care. Task shifting models that have proven effective for other programs including diabetes mellitus control program, which involves training community health workers, such as ASHAs and ANMs, can increase awareness reduce stigma and promoting early detection. Embedding PCOS management into reproductive and maternal health programs can utilize existing infrastructure for better resource utilization. Simultaneously, establishing national guidelines tailored to resource-constrained settings ensures equitable and consistent care delivery.</p>
<p>While lowcost options like metformin are available, care should be taken to prescribe those cost-efficient medications though primary care centres, and subsidized tertiary care can ensure access to care, and catastrophic expenditure for low-income populations. Research into cost-effective diagnostic tools, scalable lifestyle interventions, and digital health solutions is vital for addressing gaps in PCOS management. A coordinated effort involving government, NGOs, and private stakeholders is crucial for comprehensive management of PCOS to achieve SDG by 2030. By prioritizing prevention, affordability, and accessibility, public health policies can reduce the burden of PCOS and help mitigate the burden of PCOS and its complications.</p>
</sec>
</body>
<back>
<sec id="s5" sec-type="author-contributions"><title>Author contributions</title>
<p>SV: Conceptualization, Methodology, Writing &#x2013; original draft. RG: Data curation, Writing &#x2013; original draft. PM: Data curation, Writing &#x2013; original draft. AA: Conceptualization, Writing &#x2013; review &#x0026; editing. MG: Conceptualization, Investigation, Writing &#x2013; review &#x0026; editing. JP: Supervision, Validation, Writing &#x2013; review &#x0026; editing. TA: Conceptualization, Project administration, Supervision, Validation, Writing &#x2013; review &#x0026; editing.</p>
</sec>
<sec id="s6" sec-type="funding-information"><title>Funding</title>
<p>The author(s) declare that financial support was received for the research and/or publication of this article. The author (s) declare financial support was received from ICMR (Indian Council of Medical Research). Grant Id-5/7/103/PCOS-phaseII/NTF/2020RBMCH.</p>
</sec>
<sec id="s7" sec-type="COI-statement"><title>Conflict of interest</title>
<p>The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.</p>
</sec>
<sec id="s8" sec-type="ai-statement"><title>Generative AI statement</title>
<p>The author(s) declare that Generative AI was used in the creation of this manuscript. Artificial intelligence assistance (Chat GPT) was used to correct grammar and spelling.</p>
<p>Any alternative text (alt text) provided alongside figures in this article has been generated by Frontiers with the support of artificial intelligence and reasonable efforts have been made to ensure accuracy, including review by the authors wherever possible. If you identify any issues, please contact us.</p>
</sec>
<sec id="s9" sec-type="disclaimer"><title>Publisher&#x0027;s note</title>
<p>All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article, or claim that may be made by its manufacturer, is not guaranteed or endorsed by the publisher.</p>
</sec>
<ref-list><title>References</title>
<ref id="B1"><label>1.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Teede</surname><given-names>HJ</given-names></name><name><surname>Misso</surname><given-names>ML</given-names></name><name><surname>Costello</surname><given-names>MF</given-names></name><name><surname>Dokras</surname><given-names>A</given-names></name><name><surname>Laven</surname><given-names>J</given-names></name><name><surname>Moran</surname><given-names>L</given-names></name><etal/></person-group> <article-title>Recommendations from the international evidence-based guideline for the assessment and management of polycystic ovary syndrome</article-title>. <source>Fertil Steril</source>. (<year>2018</year>) <volume>110</volume>(<issue>3</issue>):<fpage>364</fpage>&#x2013;<lpage>79</lpage>. <pub-id pub-id-type="doi">10.1016/j.fertnstert.2018.05.004</pub-id><pub-id pub-id-type="pmid">30033227</pub-id></citation></ref>
<ref id="B2"><label>2.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Nidhi</surname><given-names>R</given-names></name><name><surname>Padmalatha</surname><given-names>V</given-names></name><name><surname>Nagarathna</surname><given-names>R</given-names></name><name><surname>Amritanshu</surname><given-names>R</given-names></name></person-group>. <article-title>Prevalence of polycystic ovarian syndrome in Indian adolescents</article-title>. <source>J Pediatr Adolesc Gynecol</source>. (<year>2011</year>) <volume>24</volume>(<issue>4</issue>):<fpage>223</fpage>&#x2013;<lpage>7</lpage>. <pub-id pub-id-type="doi">10.1016/j.jpag.2011.03.002</pub-id><pub-id pub-id-type="pmid">21600812</pub-id></citation></ref>
<ref id="B3"><label>3.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Lizneva</surname><given-names>D</given-names></name><name><surname>Suturina</surname><given-names>L</given-names></name><name><surname>Walker</surname><given-names>W</given-names></name><name><surname>Brakta</surname><given-names>S</given-names></name><name><surname>Gavrilova-Jordan</surname><given-names>L</given-names></name><name><surname>Azziz</surname><given-names>R</given-names></name></person-group>. <article-title>Criteria, prevalence, and phenotypes of polycystic ovary syndrome</article-title>. <source>Fertil Steril</source>. (<year>2016</year>) <volume>106</volume>(<issue>1</issue>):<fpage>6</fpage>&#x2013;<lpage>15</lpage>. <pub-id pub-id-type="doi">10.1016/j.fertnstert.2016.05.003</pub-id><pub-id pub-id-type="pmid">27233760</pub-id></citation></ref>
<ref id="B4"><label>4.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Goodarzi</surname><given-names>MO</given-names></name><name><surname>Dumesic</surname><given-names>DA</given-names></name><name><surname>Chazenbalk</surname><given-names>G</given-names></name><name><surname>Azziz</surname><given-names>R</given-names></name></person-group>. <article-title>Polycystic ovary syndrome: etiology, pathogenesis and diagnosis</article-title>. <source>Nat Rev Endocrinol</source>. (<year>2011</year>) <volume>7</volume>(<issue>4</issue>):<fpage>219</fpage>&#x2013;<lpage>31</lpage>. <pub-id pub-id-type="doi">10.1038/nrendo.2010.217</pub-id><pub-id pub-id-type="pmid">21263450</pub-id></citation></ref>
<ref id="B5"><label>5.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Escobar-Morreale</surname><given-names>HF</given-names></name></person-group>. <article-title>Polycystic ovary syndrome: definition, aetiology, diagnosis and treatment</article-title>. <source>Nat Rev Endocrinol</source>. (<year>2018</year>) <volume>14</volume>(<issue>5</issue>):<fpage>270</fpage>&#x2013;<lpage>84</lpage>. <pub-id pub-id-type="doi">10.1038/nrendo.2018.24</pub-id><pub-id pub-id-type="pmid">29569621</pub-id></citation></ref>
<ref id="B6"><label>6.</label><citation citation-type="other"><collab>World Bank Country and Lending Groups</collab>. <article-title>World bank data help desk</article-title>. <comment>Available online at:</comment> <ext-link ext-link-type="uri" xlink:href="https://datahelpdesk.worldbank.org/knowledgebase/articles/906519-world-bank-country-and-lending-groups">https://datahelpdesk.worldbank.org/knowledgebase/articles/906519-world-bank-country-and-lending-groups</ext-link> <comment>(Accessed May 01, 2025)</comment>.</citation></ref>
<ref id="B7"><label>7.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Berni</surname><given-names>TR</given-names></name><name><surname>Morgan</surname><given-names>CL</given-names></name><name><surname>Rees</surname><given-names>DA</given-names></name></person-group>. <article-title>Rising incidence, health resource utilization, and costs of polycystic ovary syndrome in the United Kingdom</article-title>. <source>J Clin Endocrinol Metab</source>. (<year>2025</year>) <volume>110</volume>(<issue>5</issue>):<fpage>e1580</fpage>&#x2013;<lpage>9</lpage>. <pub-id pub-id-type="doi">10.1210/clinem/dgae518</pub-id><pub-id pub-id-type="pmid">39049776</pub-id></citation></ref>
<ref id="B8"><label>8.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Baheiraei</surname><given-names>A</given-names></name><name><surname>Bakouei</surname><given-names>F</given-names></name><name><surname>Mohammadi</surname><given-names>E</given-names></name><name><surname>Montazeri</surname><given-names>A</given-names></name><name><surname>Hosseni</surname><given-names>M</given-names></name></person-group>. <article-title>The social determinants of health in association with women&#x2019;s health Status of reproductive age: a population-based study</article-title>. <source>Iran J Public Health</source>. (<year>2015</year>) <volume>44</volume>(<issue>1</issue>):<fpage>119</fpage>. <comment>Available online at:</comment> <ext-link ext-link-type="uri" xlink:href="https://pmc.ncbi.nlm.nih.gov/articles/PMC4449998/">https://pmc.ncbi.nlm.nih.gov/articles/PMC4449998/</ext-link><pub-id pub-id-type="pmid">26060783</pub-id></citation></ref>
<ref id="B9"><label>9.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Chen</surname><given-names>X</given-names></name><name><surname>Orom</surname><given-names>H</given-names></name><name><surname>Hay</surname><given-names>JL</given-names></name><name><surname>Waters</surname><given-names>EA</given-names></name><name><surname>Schofield</surname><given-names>E</given-names></name><name><surname>Li</surname><given-names>Y</given-names></name><etal/></person-group> <article-title>Differences in rural and urban health information access and use</article-title>. <source>J Rural Heal</source>. (<year>2019</year>) <volume>35</volume>(<issue>3</issue>):<fpage>405</fpage>&#x2013;<lpage>17</lpage>. <pub-id pub-id-type="doi">10.1111/jrh.12335</pub-id></citation></ref>
<ref id="B10"><label>10.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Wasata</surname><given-names>R</given-names></name><name><surname>Chertok</surname><given-names>IRA</given-names></name><name><surname>Kingori</surname><given-names>C</given-names></name><name><surname>Haile</surname><given-names>ZT</given-names></name></person-group>. <article-title>Exploratory study of knowledge and experience of polycystic ovary syndrome (PCOS) among PCOS-diagnosed Bangladeshi women</article-title>. <source>J Women Health Care Issues</source>. (<year>2020</year>) <volume>3</volume>(<issue>1</issue>):<fpage>1</fpage>&#x2013;<lpage>9</lpage>. <comment>Available online at:</comment> <ext-link ext-link-type="uri" xlink:href="www.auctoresonline.org">www.auctoresonline.org</ext-link></citation></ref>
<ref id="B11"><label>11.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Makwe</surname><given-names>CC</given-names></name><name><surname>Olamijulo</surname><given-names>JA</given-names></name><name><surname>Balogun</surname><given-names>MR</given-names></name><name><surname>Akinkugbe</surname><given-names>AO</given-names></name><name><surname>Samuel</surname><given-names>A</given-names></name><name><surname>Udenze</surname><given-names>K</given-names></name><etal/></person-group> <article-title>SAT363 The prevalence and phenotype of polycystic ovary syndrome (PCOS) in A community-based population in sub-sahara Africa: the Nigeria-PEP study</article-title>. <source>J Endocr Soc</source>. (<year>2023</year>) <volume>7</volume>(<issue>Suppl 1</issue>):<fpage>bvad114.1668</fpage>. <pub-id pub-id-type="doi">10.1210/jendso/bvad114.1668</pub-id></citation></ref>
<ref id="B12"><label>12.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Riestenberg</surname><given-names>C</given-names></name><name><surname>Jagasia</surname><given-names>A</given-names></name><name><surname>Markovic</surname><given-names>D</given-names></name><name><surname>Buyalos</surname><given-names>RP</given-names></name><name><surname>Azziz</surname><given-names>R</given-names></name></person-group>. <article-title>Health care-related economic burden of polycystic ovary syndrome in the United States: pregnancy-related and long-term health consequences</article-title>. <source>J Clin Endocrinol Metab</source>. (<year>2022</year>) <volume>107</volume>(<issue>2</issue>):<fpage>575</fpage>&#x2013;<lpage>85</lpage>. <pub-id pub-id-type="doi">10.1210/clinem/dgab613</pub-id><pub-id pub-id-type="pmid">34546364</pub-id></citation></ref>
<ref id="B13"><label>13.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Levitt</surname><given-names>NS</given-names></name><name><surname>Steyn</surname><given-names>K</given-names></name><name><surname>Dave</surname><given-names>J</given-names></name><name><surname>Bradshaw</surname><given-names>D</given-names></name></person-group>. <article-title>Chronic noncommunicable diseases and HIV-AIDS on a collision course: relevance for health care delivery, particularly in low-resource settings&#x2014;insights from South Africa</article-title>. <source>Am J Clin Nutr</source>. (<year>2011</year>) <volume>94</volume>(<issue>6</issue>):<fpage>1690S</fpage>&#x2013;<lpage>6</lpage>. <pub-id pub-id-type="doi">10.3945/ajcn.111.019075</pub-id><pub-id pub-id-type="pmid">22089433</pub-id></citation></ref>
<ref id="B14"><label>14.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Macinko</surname><given-names>J</given-names></name><name><surname>Harris</surname><given-names>MJ</given-names></name></person-group>. <article-title>Brazil&#x2019;s family health strategy&#x2014;delivering community-based primary care in a universal health system</article-title>. <source>N Engl J Med</source>. (<year>2015</year>) <volume>372</volume>(<issue>23</issue>):<fpage>2177</fpage>&#x2013;<lpage>81</lpage>. <pub-id pub-id-type="doi">10.1056/NEJMp1501140</pub-id><pub-id pub-id-type="pmid">26039598</pub-id></citation></ref>
<ref id="B15"><label>15.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Dabare</surname><given-names>PRL</given-names></name><name><surname>Wanigatunge</surname><given-names>CA</given-names></name><name><surname>Beneragama</surname><given-names>BH</given-names></name></person-group>. <article-title>A national survey on availability, price and affordability of selected essential medicines for non communicable diseases in Sri Lanka</article-title>. <source>BMC Public Health</source>. (<year>2014</year>) <volume>14</volume>(<issue>1</issue>):<fpage>817</fpage>. <pub-id pub-id-type="doi">10.1186/1471-2458-14-817</pub-id><pub-id pub-id-type="pmid">25103467</pub-id></citation></ref>
<ref id="B16"><label>16.</label><citation citation-type="other"><collab>University of California San Francisco</collab>. <article-title>UCSF multidisciplinary clinic for women with polycystic ovary syndrome</article-title>. <comment>Available online at:</comment> <ext-link ext-link-type="uri" xlink:href="https://pcos.ucsf.edu/">https://pcos.ucsf.edu/</ext-link> <comment>(Accessed May 01, 2025)</comment>.</citation></ref>
<ref id="B17"><label>17.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Srinivas</surname><given-names>V</given-names></name><name><surname>Choubey</surname><given-names>U</given-names></name><name><surname>Motwani</surname><given-names>J</given-names></name><name><surname>Anamika</surname><given-names>F</given-names></name><name><surname>Chennupati</surname><given-names>C</given-names></name><name><surname>Garg</surname><given-names>N</given-names></name><etal/></person-group> <article-title>Synergistic strategies: optimizing outcomes through a multidisciplinary approach to clinical rounds</article-title>. <source>Proc (Bayl Univ Med Cent)</source>. (<year>2023</year>) <volume>37</volume>(<issue>1</issue>):<fpage>144</fpage>. <comment>Available online at:</comment> <ext-link ext-link-type="uri" xlink:href="https://pmc.ncbi.nlm.nih.gov/articles/PMC10761132/">https://pmc.ncbi.nlm.nih.gov/articles/PMC10761132/</ext-link><pub-id pub-id-type="pmid">38174031</pub-id></citation></ref>
<ref id="B18"><label>18.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Haleem</surname><given-names>A</given-names></name><name><surname>Javaid</surname><given-names>M</given-names></name><name><surname>Singh</surname><given-names>RP</given-names></name><name><surname>Suman</surname><given-names>R</given-names></name></person-group>. <article-title>Telemedicine for healthcare: capabilities, features, barriers, and applications</article-title>. <source>Sensors Int</source>. (<year>2021</year>) <volume>2</volume>:<fpage>100117</fpage>. <pub-id pub-id-type="doi">10.1016/j.sintl.2021.100117</pub-id></citation></ref>
<ref id="B19"><label>19.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Almhmoud</surname><given-names>H</given-names></name><name><surname>Alatassi</surname><given-names>L</given-names></name><name><surname>Baddoura</surname><given-names>M</given-names></name><name><surname>Sandouk</surname><given-names>J</given-names></name><name><surname>Alkayali</surname><given-names>MZ</given-names></name><name><surname>Najjar</surname><given-names>H</given-names></name><etal/></person-group> <article-title>Polycystic ovary syndrome and its multidimensional impacts on women&#x2019;s mental health: a narrative review</article-title>. <source>Medicine (Baltimore)</source>. (<year>2024</year>) <volume>103</volume>(<issue>25</issue>):<fpage>e38647</fpage>. <pub-id pub-id-type="doi">10.1097/MD.0000000000038647</pub-id><pub-id pub-id-type="pmid">38905372</pub-id></citation></ref>
<ref id="B20"><label>20.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Mennella</surname><given-names>C</given-names></name><name><surname>Maniscalco</surname><given-names>U</given-names></name><name><surname>De Pietro</surname><given-names>G</given-names></name><name><surname>Esposito</surname><given-names>M</given-names></name></person-group>. <article-title>Ethical and regulatory challenges of AI technologies in healthcare: a narrative review</article-title>. <source>Heliyon</source>. (<year>2024</year>) <volume>10</volume>(<issue>4</issue>):<fpage>e26297</fpage>. <pub-id pub-id-type="doi">10.1016/j.heliyon.2024.e26297</pub-id><pub-id pub-id-type="pmid">38384518</pub-id></citation></ref>
<ref id="B21"><label>21.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Calcagno</surname><given-names>M</given-names></name><name><surname>Serra</surname><given-names>P</given-names></name><name><surname>Etrusco</surname><given-names>A</given-names></name><name><surname>Margioula-Siarkou</surname><given-names>C</given-names></name><name><surname>Terzic</surname><given-names>S</given-names></name><name><surname>Giannini</surname><given-names>A</given-names></name><etal/></person-group> <article-title>A bitter pill to swallow: adjustments to oral contraceptive pill use in polycystic ovary syndrome</article-title>. <source>Expert Opin Pharmacother</source>. (<year>2024</year>) <volume>25</volume>(<issue>9</issue>):<fpage>1137</fpage>&#x2013;<lpage>43</lpage>. <pub-id pub-id-type="doi">10.1080/14656566.2024.2371977</pub-id><pub-id pub-id-type="pmid">38904185</pub-id></citation></ref>
<ref id="B22"><label>22.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Christ</surname><given-names>JP</given-names></name><name><surname>Cedars</surname><given-names>MI</given-names></name></person-group>. <article-title>Current guidelines for diagnosing PCOS</article-title>. <source>Diagnostics (Basel, Switzerland)</source>. (<year>2023</year>) <volume>13</volume>(<issue>6</issue>):<fpage>1113</fpage>. <pub-id pub-id-type="doi">10.3390/diagnostics13061113</pub-id><pub-id pub-id-type="pmid">36980421</pub-id></citation></ref>
<ref id="B23"><label>23.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Dumesic</surname><given-names>DA</given-names></name><name><surname>Oberfield</surname><given-names>SE</given-names></name><name><surname>Stener-Victorin</surname><given-names>E</given-names></name><name><surname>Marshall</surname><given-names>JC</given-names></name><name><surname>Laven</surname><given-names>JS</given-names></name><name><surname>Legro</surname><given-names>RS</given-names></name></person-group>. <article-title>Scientific statement on the diagnostic criteria, epidemiology, pathophysiology, and molecular genetics of polycystic ovary syndrome</article-title>. <source>Endocr Rev</source>. (<year>2015</year>) <volume>36</volume>(<issue>5</issue>):<fpage>487</fpage>&#x2013;<lpage>525</lpage>. <pub-id pub-id-type="doi">10.1210/er.2015-1018</pub-id><pub-id pub-id-type="pmid">26426951</pub-id></citation></ref>
<ref id="B24"><label>24.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Legro</surname><given-names>RS</given-names></name><name><surname>Arslanian</surname><given-names>SA</given-names></name><name><surname>Ehrmann</surname><given-names>DA</given-names></name><name><surname>Hoeger</surname><given-names>KM</given-names></name><name><surname>Murad</surname><given-names>MH</given-names></name><name><surname>Pasquali</surname><given-names>R</given-names></name><etal/></person-group> <article-title>Diagnosis and treatment of polycystic ovary syndrome: an endocrine society clinical practice guideline</article-title>. <source>J Clin Endocrinol Metab</source>. (<year>2013</year>) <volume>98</volume>(<issue>12</issue>):<fpage>4565</fpage>&#x2013;<lpage>92</lpage>. <pub-id pub-id-type="doi">10.1210/jc.2013-2350</pub-id><pub-id pub-id-type="pmid">24151290</pub-id></citation></ref>
<ref id="B25"><label>25.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Chang</surname><given-names>S</given-names></name><name><surname>Dunaif</surname><given-names>A</given-names></name></person-group>. <article-title>Diagnosis of polycystic ovary syndrome: which criteria to use and when?</article-title> <source>Endocrinol Metab Clin North Am</source>. (<year>2021</year>) <volume>50</volume>(<issue>1</issue>):<fpage>11</fpage>&#x2013;<lpage>23</lpage>. <pub-id pub-id-type="doi">10.1016/j.ecl.2020.10.002</pub-id><pub-id pub-id-type="pmid">33518179</pub-id></citation></ref>
<ref id="B26"><label>26.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Joham</surname><given-names>AE</given-names></name><name><surname>Tay</surname><given-names>CT</given-names></name><name><surname>Laven</surname><given-names>J</given-names></name><name><surname>Louwers</surname><given-names>YV</given-names></name><name><surname>Azziz</surname><given-names>R</given-names></name></person-group>. <article-title>Approach to the patient: diagnostic challenges in the workup for polycystic ovary syndrome</article-title>. <source>J Clin Endocrinol Metab</source>. (<year>2025</year>) <volume>110</volume>(<issue>7</issue>):<fpage>e2298</fpage>&#x2013;<lpage>308</lpage>. <pub-id pub-id-type="doi">10.1210/clinem/dgae910</pub-id><pub-id pub-id-type="pmid">39836632</pub-id></citation></ref>
<ref id="B27"><label>27.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Vasudevan</surname><given-names>S</given-names></name></person-group>. <article-title>Menstrual health and hygiene practices of adolescent girls attending school in rural parts of south India and its effect on school attendance in the year 2020: a descriptive cross-sectional study</article-title>. <source>Int J Med Sci Nurs Res</source>. (<year>2024</year>) <volume>4</volume>(<issue>3</issue>):<fpage>6</fpage>&#x2013;<lpage>14</lpage>. <pub-id pub-id-type="doi">10.55349/ijmsnr.202443614</pub-id></citation></ref>
<ref id="B28"><label>28.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Pascoal</surname><given-names>E</given-names></name><name><surname>Wessels</surname><given-names>JM</given-names></name><name><surname>Aas-Eng</surname><given-names>MK</given-names></name><name><surname>Abrao</surname><given-names>MS</given-names></name><name><surname>Condous</surname><given-names>G</given-names></name><name><surname>Jurkovic</surname><given-names>D</given-names></name><etal/></person-group> <article-title>Strengths and limitations of diagnostic tools for endometriosis and relevance in diagnostic test accuracy research</article-title>. <source>Ultrasound Obstet Gynecol</source>. (<year>2022</year>) <volume>60</volume>(<issue>3</issue>):<fpage>309</fpage>&#x2013;<lpage>27</lpage>. <pub-id pub-id-type="doi">10.1002/uog.24892</pub-id><pub-id pub-id-type="pmid">35229963</pub-id></citation></ref>
<ref id="B29"><label>29.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Peterman</surname><given-names>NJ</given-names></name><name><surname>Yeo</surname><given-names>E</given-names></name><name><surname>Kaptur</surname><given-names>B</given-names></name><name><surname>Smith</surname><given-names>EJ</given-names></name><name><surname>Christensen</surname><given-names>A</given-names></name><name><surname>Huang</surname><given-names>E</given-names></name><etal/></person-group> <article-title>Analysis of rural disparities in ultrasound access</article-title>. <source>Cureus</source>. (<year>2022</year>) <volume>14</volume>(<issue>5</issue>):<fpage>e25425</fpage>. <comment>Available online at:</comment> <ext-link ext-link-type="uri" xlink:href="https://pmc.ncbi.nlm.nih.gov/articles/PMC9236672/">https://pmc.ncbi.nlm.nih.gov/articles/PMC9236672/</ext-link><pub-id pub-id-type="pmid">35774712</pub-id></citation></ref>
<ref id="B30"><label>30.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Meczekalski</surname><given-names>B</given-names></name><name><surname>Niwczyk</surname><given-names>O</given-names></name><name><surname>Kostrzak</surname><given-names>A</given-names></name><name><surname>Maciejewska-Jeske</surname><given-names>M</given-names></name><name><surname>Bala</surname><given-names>G</given-names></name><name><surname>Szeliga</surname><given-names>A</given-names></name></person-group>. <article-title>PCOS In adolescents-ongoing riddles in diagnosis and treatment</article-title>. <source>J Clin Med</source>. (<year>2023</year>) <volume>12</volume>(<issue>3</issue>):<fpage>1221</fpage>. <pub-id pub-id-type="doi">10.3390/jcm12031221</pub-id><pub-id pub-id-type="pmid">36769869</pub-id></citation></ref>
<ref id="B31"><label>31.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Roberts</surname><given-names>L</given-names></name><name><surname>Renati</surname><given-names>S</given-names></name><name><surname>Solomon</surname><given-names>S</given-names></name><name><surname>Montgomery</surname><given-names>S</given-names></name></person-group>. <article-title>Women and infertility in a pronatalist culture: mental health in the slums of mumbai</article-title>. <source>Int J Womens Health</source>. (<year>2020</year>) <volume>12</volume>:<fpage>993</fpage>&#x2013;<lpage>1003</lpage>. <pub-id pub-id-type="doi">10.2147/IJWH.S273149</pub-id><pub-id pub-id-type="pmid">33192102</pub-id></citation></ref>
<ref id="B32"><label>32.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Pe&#x00F1;a</surname><given-names>AS</given-names></name><name><surname>Witchel</surname><given-names>SF</given-names></name><name><surname>Hoeger</surname><given-names>KM</given-names></name><name><surname>Oberfield</surname><given-names>SE</given-names></name><name><surname>Vogiatzi</surname><given-names>MG</given-names></name><name><surname>Misso</surname><given-names>M</given-names></name><etal/></person-group> <article-title>Adolescent polycystic ovary syndrome according to the international evidence-based guideline</article-title>. <source>BMC Med</source>. (<year>2020</year>) <volume>18</volume>(<issue>1</issue>):<fpage>1</fpage>&#x2013;<lpage>16</lpage>. <pub-id pub-id-type="doi">10.1186/s12916-020-01516-x</pub-id></citation></ref>
<ref id="B33"><label>33.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Olson</surname><given-names>MM</given-names></name><name><surname>Alhelou</surname><given-names>N</given-names></name><name><surname>Kavattur</surname><given-names>PS</given-names></name><name><surname>Rountree</surname><given-names>L</given-names></name><name><surname>Winkler</surname><given-names>IT</given-names></name></person-group>. <article-title>The persistent power of stigma: a critical review of policy initiatives to break the menstrual silence and advance menstrual literacy</article-title>. <source>PLOS Glob Public Heal</source>. (<year>2022</year>) <volume>2</volume>(<issue>7</issue>):<fpage>e0000070</fpage>.</citation></ref>
<ref id="B34"><label>34.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Yesiladali</surname><given-names>M</given-names></name><name><surname>Yazici</surname><given-names>MGK</given-names></name><name><surname>Attar</surname><given-names>E</given-names></name><name><surname>Kelestimur</surname><given-names>F</given-names></name></person-group>. <article-title>Differentiating polycystic ovary syndrome from adrenal disorders</article-title>. <source>Diagnostics</source>. (<year>2022</year>) <volume>12</volume>(<issue>9</issue>):<fpage>1</fpage>&#x2013;<lpage>14</lpage>. <pub-id pub-id-type="doi">10.3390/diagnostics12092045</pub-id></citation></ref>
<ref id="B35"><label>35.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Myers</surname><given-names>A</given-names></name><name><surname>Sami</surname><given-names>S</given-names></name><name><surname>Onyango</surname><given-names>MA</given-names></name><name><surname>Karki</surname><given-names>H</given-names></name><name><surname>Anggraini</surname><given-names>R</given-names></name><name><surname>Krause</surname><given-names>S</given-names></name></person-group>. <article-title>Facilitators and barriers in implementing the Minimum initial services package (MISP) for reproductive health in Nepal post-earthquake</article-title>. <source>Confl Health</source>. (<year>2018</year>) <volume>12</volume>(<issue>1</issue>):<fpage>1</fpage>&#x2013;<lpage>9</lpage>. <pub-id pub-id-type="doi">10.1186/s13031-018-0170-0</pub-id><pub-id pub-id-type="pmid">29449879</pub-id></citation></ref>
<ref id="B36"><label>36.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Schmitt</surname><given-names>ML</given-names></name><name><surname>Clatworthy</surname><given-names>D</given-names></name><name><surname>Ratnayake</surname><given-names>R</given-names></name><name><surname>Klaesener-Metzner</surname><given-names>N</given-names></name><name><surname>Roesch</surname><given-names>E</given-names></name><name><surname>Wheeler</surname><given-names>E</given-names></name><etal/></person-group> <article-title>Understanding the menstrual hygiene management challenges facing displaced girls and women: findings from qualitative assessments in Myanmar and Lebanon</article-title>. <source>Confl Health</source>. (<year>2017</year>) <volume>11</volume>(<issue>1</issue>):<fpage>1</fpage>&#x2013;<lpage>11</lpage>. <pub-id pub-id-type="doi">10.1186/s13031-017-0121-1</pub-id><pub-id pub-id-type="pmid">28101127</pub-id></citation></ref>
<ref id="B37"><label>37.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Gautam</surname><given-names>R</given-names></name><name><surname>Jyoti</surname><given-names>A</given-names></name><name><surname>Bhateja</surname><given-names>A</given-names></name><name><surname>Malhotra</surname><given-names>N</given-names></name><name><surname>Arora</surname><given-names>T</given-names></name></person-group>. <article-title>Pharmacological management of PCOS: trends and insights from a 10-year bibliometric analysis</article-title>. <source>Expert Opin Pharmacother</source>. (<year>2025</year>) <volume>26</volume>(<issue>11&#x2013;12</issue>):<fpage>1351</fpage>&#x2013;<lpage>8</lpage>. <pub-id pub-id-type="doi">10.1080/14656566.2025.2535175</pub-id><pub-id pub-id-type="pmid">40661050</pub-id></citation></ref>
<ref id="B38"><label>38.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Gautam</surname><given-names>R</given-names></name><name><surname>Bhateja</surname><given-names>A</given-names></name><name><surname>Malhotra</surname><given-names>N</given-names></name><name><surname>Arora</surname><given-names>T</given-names></name></person-group>. <article-title>Mapping the research landscape of lifestyle modification in PCOS management: a 10 year bibliometric analysis</article-title>. <source>Clin Epidemiol Glob Heal</source>. (<year>2025</year>) <volume>33</volume>:<fpage>102024</fpage>. <pub-id pub-id-type="doi">10.1016/j.cegh.2025.102024</pub-id></citation></ref>
<ref id="B39"><label>39.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Kodali</surname><given-names>PB</given-names></name></person-group>. <article-title>Achieving universal health coverage in low- and middle-income countries: challenges for policy post-pandemic and beyond</article-title>. <source>Risk Manag Healthc Policy</source>. (<year>2023</year>) <volume>16</volume>:<fpage>607</fpage>&#x2013;<lpage>21</lpage>. <pub-id pub-id-type="doi">10.2147/RMHP.S366759</pub-id><pub-id pub-id-type="pmid">37050920</pub-id></citation></ref>
<ref id="B40"><label>40.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Joham</surname><given-names>AE</given-names></name><name><surname>Piltonen</surname><given-names>T</given-names></name><name><surname>Lujan</surname><given-names>ME</given-names></name><name><surname>Kiconco</surname><given-names>S</given-names></name><name><surname>Tay</surname><given-names>CT</given-names></name></person-group>. <article-title>Challenges in diagnosis and understanding of natural history of polycystic ovary syndrome</article-title>. <source>Clin Endocrinol (Oxf)</source>. (<year>2022</year>) <volume>97</volume>(<issue>2</issue>):<fpage>165</fpage>&#x2013;<lpage>73</lpage>. <pub-id pub-id-type="doi">10.1111/cen.14757</pub-id><pub-id pub-id-type="pmid">35593530</pub-id></citation></ref>
<ref id="B41"><label>41.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Shukla</surname><given-names>A</given-names></name><name><surname>Ashraf</surname><given-names>GM</given-names></name><name><surname>Sudharsan</surname><given-names>V</given-names></name><name><surname>Arora</surname><given-names>T</given-names></name><name><surname>Rather</surname><given-names>KUI</given-names></name><name><surname>Chowdhury</surname><given-names>S</given-names></name><etal/></person-group> <article-title>Trends of age at onset of menarche among Indian women of reproductive age and its association with the presence of PCOS and related features: a multicentric cross sectional study</article-title>. <source>J Obstet Gynecol India</source>. (<year>2025</year>) <volume>75</volume>(<issue>1</issue>):<fpage>70</fpage>&#x2013;<lpage>7</lpage>. <pub-id pub-id-type="doi">10.1007/s13224-024-01994-6</pub-id></citation></ref>
<ref id="B42"><label>42.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Rajkumar</surname><given-names>E</given-names></name><name><surname>Ardra</surname><given-names>A</given-names></name><name><surname>Prabhu</surname><given-names>G</given-names></name><name><surname>Pandey</surname><given-names>V</given-names></name><name><surname>Sundaramoorthy</surname><given-names>J</given-names></name><name><surname>Manzoor</surname><given-names>R</given-names></name><etal/></person-group> <article-title>Polycystic ovary syndrome: an exploration of unmarried women&#x2019;s knowledge and attitudes</article-title>. <source>HELIYON</source>. (<year>2022</year>) <volume>8</volume>(<issue>7</issue>):<fpage>e09835</fpage>. <pub-id pub-id-type="doi">10.1016/j.heliyon.2022.e09835</pub-id><pub-id pub-id-type="pmid">35832347</pub-id></citation></ref>
<ref id="B43"><label>43.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Dewani</surname><given-names>D</given-names></name><name><surname>Karwade</surname><given-names>P</given-names></name><name><surname>Mahajan</surname><given-names>KS</given-names></name></person-group>. <article-title>The invisible struggle: the psychosocial aspects of polycystic ovary syndrome</article-title>. <source>Cureus</source>. (<year>2023</year>) <volume>15</volume>(<issue>12</issue>):<fpage>1</fpage>&#x2013;<lpage>8</lpage>.</citation></ref>
<ref id="B44"><label>44.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Jannink</surname><given-names>T</given-names></name><name><surname>Bordewijk</surname><given-names>EM</given-names></name><name><surname>Aalberts</surname><given-names>J</given-names></name><name><surname>Hendriks</surname><given-names>J</given-names></name><name><surname>Lehmann</surname><given-names>V</given-names></name><name><surname>Hoek</surname><given-names>A</given-names></name><etal/></person-group> <article-title>Anxiety, depression, and body image among infertile women with and without polycystic ovary syndrome</article-title>. <source>Hum Reprod</source>. (<year>2024</year>) <volume>39</volume>(<issue>4</issue>):<fpage>784</fpage>&#x2013;<lpage>91</lpage>. <pub-id pub-id-type="doi">10.1093/humrep/deae016</pub-id><pub-id pub-id-type="pmid">38335234</pub-id></citation></ref>
<ref id="B45"><label>45.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Cowan</surname><given-names>S</given-names></name><name><surname>Lim</surname><given-names>S</given-names></name><name><surname>Alycia</surname><given-names>C</given-names></name><name><surname>Pirotta</surname><given-names>S</given-names></name><name><surname>Thomson</surname><given-names>R</given-names></name><name><surname>Helm</surname><given-names>MG</given-names></name><etal/></person-group> <article-title>Lifestyle management in polycystic ovary syndrome&#x2014;beyond diet and physical activity</article-title>. <source>BMC Endocr Disord</source>. (<year>2023</year>) <volume>23</volume>:<fpage>1</fpage>&#x2013;<lpage>33</lpage>. <pub-id pub-id-type="doi">10.1186/s12902-022-01208-y</pub-id><pub-id pub-id-type="pmid">36597121</pub-id></citation></ref>
<ref id="B46"><label>46.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Serour</surname><given-names>M</given-names></name><name><surname>Alqhenaei</surname><given-names>H</given-names></name><name><surname>Al-Saqabi</surname><given-names>S</given-names></name><name><surname>Mustafa</surname><given-names>AR</given-names></name><name><surname>Ben-Nakhi</surname><given-names>A</given-names></name></person-group>. <article-title>Cultural factors and patients&#x2019; adherence to lifestyle measures</article-title>. <source>Br J Gen Pract</source>. (<year>2007</year>) <volume>57</volume>(<issue>537</issue>):<fpage>291</fpage>. <comment>Available online at:</comment> <ext-link ext-link-type="uri" xlink:href="https://pmc.ncbi.nlm.nih.gov/articles/PMC2043336/">https://pmc.ncbi.nlm.nih.gov/articles/PMC2043336/</ext-link><pub-id pub-id-type="pmid">17394732</pub-id></citation></ref>
<ref id="B47"><label>47.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Solini</surname><given-names>A</given-names></name><name><surname>Tric&#x00F2;</surname><given-names>D</given-names></name></person-group>. <article-title>Clinical efficacy and cost-effectiveness of metformin in different patient populations: a narrative review of real-world evidence</article-title>. <source>Diabetes Obes Metab</source>. (<year>2024</year>) <volume>26</volume>(<issue>S3</issue>):<fpage>20</fpage>&#x2013;<lpage>30</lpage>. <pub-id pub-id-type="doi">10.1111/dom.15729</pub-id><pub-id pub-id-type="pmid">38939954</pub-id></citation></ref>
<ref id="B48"><label>48.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Maan</surname><given-names>P</given-names></name><name><surname>Gautam</surname><given-names>R</given-names></name><name><surname>Vasudevan</surname><given-names>S</given-names></name><name><surname>Menon</surname><given-names>GR</given-names></name><name><surname>Arora</surname><given-names>A</given-names></name><name><surname>Nair</surname><given-names>A</given-names></name><etal/></person-group> <article-title>Pharmacological and non-pharmacological interventions for polycystic ovary syndrome (PCOS) in Indian women: a systematic review and meta-analysis</article-title>. <source>Pharm</source>. (<year>2025</year>) <volume>18</volume>(<issue>5</issue>):<fpage>680</fpage>. <comment>Available online at:</comment> <ext-link ext-link-type="uri" xlink:href="https://www.mdpi.com/1424-8247/18/5/680/htm">https://www.mdpi.com/1424-8247/18/5/680/htm</ext-link></citation></ref>
<ref id="B49"><label>49.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Balaji</surname><given-names>S</given-names></name><name><surname>Amadi</surname><given-names>C</given-names></name><name><surname>Prasad</surname><given-names>S</given-names></name><name><surname>Kasav</surname><given-names>JB</given-names></name><name><surname>Upadhyay</surname><given-names>V</given-names></name><name><surname>Singh</surname><given-names>AK</given-names></name><etal/></person-group> <article-title>Urban rural comparisons of polycystic ovary syndrome burden among adolescent girls in a hospital setting in India</article-title>. <source>Biomed Res Int</source>. (<year>2015</year>) <volume>2015</volume>:<fpage>158951</fpage>. <pub-id pub-id-type="doi">10.1155/2015/158951</pub-id><pub-id pub-id-type="pmid">25629036</pub-id></citation></ref>
<ref id="B50"><label>50.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Rosenfield</surname><given-names>RL</given-names></name><name><surname>Ehrmann</surname><given-names>DA</given-names></name></person-group>. <article-title>The pathogenesis of polycystic ovary syndrome (PCOS): the hypothesis of PCOS as functional ovarian hyperandrogenism revisited</article-title>. <source>Endocr Rev</source>. (<year>2016</year>) <volume>37</volume>(<issue>5</issue>):<fpage>467</fpage>&#x2013;<lpage>520</lpage>. <pub-id pub-id-type="doi">10.1210/er.2015-1104</pub-id><pub-id pub-id-type="pmid">27459230</pub-id></citation></ref>
<ref id="B51"><label>51.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Schwarz</surname><given-names>T</given-names></name><name><surname>Schmidt</surname><given-names>AE</given-names></name><name><surname>Bobek</surname><given-names>J</given-names></name><name><surname>Ladurner</surname><given-names>J</given-names></name></person-group>. <article-title>Barriers to accessing health care for people with chronic conditions: a qualitative interview study</article-title>. <source>BMC Health Serv Res</source>. (<year>2022</year>) <volume>22</volume>(<issue>1</issue>):<fpage>1</fpage>&#x2013;<lpage>15</lpage>. <pub-id pub-id-type="doi">10.1186/s12913-022-08426-z</pub-id><pub-id pub-id-type="pmid">34974828</pub-id></citation></ref>
<ref id="B52"><label>52.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>El-Tallawy</surname><given-names>SN</given-names></name><name><surname>Pergolizzi</surname><given-names>JV</given-names></name><name><surname>Vasiliu-Feltes</surname><given-names>I</given-names></name><name><surname>Ahmed</surname><given-names>RS</given-names></name><name><surname>LeQuang</surname><given-names>JAK</given-names></name><name><surname>Alzahrani</surname><given-names>T</given-names></name><etal/></person-group> <article-title>Innovative applications of telemedicine and other digital health solutions in pain management: a literature review</article-title>. <source>Pain Ther</source>. (<year>2024</year>) <volume>13</volume>(<issue>4</issue>):<fpage>791</fpage>&#x2013;<lpage>812</lpage>. <pub-id pub-id-type="doi">10.1007/s40122-024-00620-7</pub-id><pub-id pub-id-type="pmid">38869690</pub-id></citation></ref>
<ref id="B53"><label>53.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Kichloo</surname><given-names>A</given-names></name><name><surname>Albosta</surname><given-names>M</given-names></name><name><surname>Dettloff</surname><given-names>K</given-names></name><name><surname>Wani</surname><given-names>F</given-names></name><name><surname>El-Amir</surname><given-names>Z</given-names></name><name><surname>Singh</surname><given-names>J</given-names></name><etal/></person-group> <article-title>Telemedicine, the current COVID-19 pandemic and the future: a narrative review and perspectives moving forward in the USA</article-title>. <source>Fam Med Community Heal</source>. (<year>2020</year>) <volume>8</volume>(<issue>3</issue>):<fpage>e000530</fpage>. <pub-id pub-id-type="doi">10.1136/fmch-2020-000530</pub-id></citation></ref>
<ref id="B54"><label>54.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Ismayilova</surname><given-names>M</given-names></name><name><surname>Yaya</surname><given-names>S</given-names></name></person-group>. <article-title>What can be done to improve polycystic ovary syndrome (PCOS) healthcare? Insights from semi-structured interviews with women in Canada</article-title>. <source>BMC Womens Health</source>. (<year>2022</year>) <volume>22</volume>(<issue>1</issue>):<fpage>1</fpage>&#x2013;<lpage>15</lpage>. <pub-id pub-id-type="doi">10.1186/s12905-022-01734-w</pub-id><pub-id pub-id-type="pmid">34986812</pub-id></citation></ref>
<ref id="B55"><label>55.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Boyle</surname><given-names>J</given-names></name><name><surname>Hollands</surname><given-names>G</given-names></name><name><surname>Beck</surname><given-names>S</given-names></name><name><surname>Hampel</surname><given-names>G</given-names></name><name><surname>Wapau</surname><given-names>H</given-names></name><name><surname>Arnot</surname><given-names>M</given-names></name><etal/></person-group> <article-title>Process evaluation of a pilot evidence-based polycystic ovary syndrome clinic in the Torres strait</article-title>. <source>Aust J Rural Health</source>. (<year>2017</year>) <volume>25</volume>(<issue>3</issue>):<fpage>175</fpage>&#x2013;<lpage>81</lpage>. <pub-id pub-id-type="doi">10.1111/ajr.12288</pub-id><pub-id pub-id-type="pmid">27086940</pub-id></citation></ref>
<ref id="B56"><label>56.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Tehrani</surname><given-names>FR</given-names></name><name><surname>Amiri</surname><given-names>M</given-names></name></person-group>. <article-title>Polycystic ovary syndrome in adolescents: challenges in diagnosis and treatment</article-title>. <source>Int J Endocrinol Metab</source>. (<year>2019</year>) <volume>17</volume>(<issue>3</issue>):<fpage>e91554</fpage>.<pub-id pub-id-type="pmid">31497042</pub-id></citation></ref>
<ref id="B57"><label>57.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Kruk</surname><given-names>ME</given-names></name><name><surname>Gage</surname><given-names>AD</given-names></name><name><surname>Arsenault</surname><given-names>C</given-names></name><name><surname>Jordan</surname><given-names>K</given-names></name><name><surname>Leslie</surname><given-names>HH</given-names></name><name><surname>Roder-DeWan</surname><given-names>S</given-names></name><etal/></person-group> <article-title>High-quality health systems in the sustainable development goals era: time for a revolution</article-title>. <source>Lancet Glob Heal</source>. (<year>2018</year>) <volume>6</volume>(<issue>11</issue>):<fpage>e1196</fpage>&#x2013;<lpage>252</lpage>. <pub-id pub-id-type="doi">10.1016/S2214-109X(18)30386-3</pub-id></citation></ref>
<ref id="B58"><label>58.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Merkin</surname><given-names>SS</given-names></name><name><surname>Azziz</surname><given-names>R</given-names></name><name><surname>Seeman</surname><given-names>T</given-names></name><name><surname>Calderon-Margalit</surname><given-names>R</given-names></name><name><surname>Daviglus</surname><given-names>M</given-names></name><name><surname>Kiefe</surname><given-names>C</given-names></name><etal/></person-group> <article-title>Socioeconomic status and polycystic ovary syndrome</article-title>. <source>J Women&#x2019;s Health</source>. (<year>2011</year>) <volume>20</volume>(<issue>3</issue>):<fpage>413</fpage>&#x2013;<lpage>9</lpage>. <pub-id pub-id-type="doi">10.1089/jwh.2010.2303</pub-id></citation></ref>
<ref id="B59"><label>59.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Okube</surname><given-names>OT</given-names></name><name><surname>Kimani</surname><given-names>S</given-names></name><name><surname>Mirie</surname><given-names>W</given-names></name></person-group>. <article-title>Community-based lifestyle intervention improves metabolic syndrome and related markers among Kenyan adults</article-title>. <source>J Diabetes Metab Disord</source>. (<year>2022</year>) <volume>21</volume>(<issue>1</issue>):<fpage>607</fpage>&#x2013;<lpage>21</lpage>. <pub-id pub-id-type="doi">10.1007/s40200-022-01023-1</pub-id><pub-id pub-id-type="pmid">35673420</pub-id></citation></ref>
<ref id="B60"><label>60.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Gautam</surname><given-names>R</given-names></name><name><surname>Maan</surname><given-names>P</given-names></name><name><surname>Jyoti</surname><given-names>A</given-names></name><name><surname>Kumar</surname><given-names>A</given-names></name><name><surname>Malhotra</surname><given-names>N</given-names></name><name><surname>Arora</surname><given-names>T</given-names></name></person-group>. <article-title>The role of lifestyle interventions in PCOS management: a systematic review</article-title>. <source>Nutrients</source>. (<year>2025</year>) <volume>17</volume>(<issue>2</issue>):<fpage>310</fpage>. <pub-id pub-id-type="doi">10.3390/nu17020310</pub-id><pub-id pub-id-type="pmid">39861440</pub-id></citation></ref>
<ref id="B61"><label>61.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Wakefield</surname><given-names>MA</given-names></name><name><surname>Loken</surname><given-names>B</given-names></name><name><surname>Hornik</surname><given-names>RC</given-names></name></person-group>. <article-title>Use of mass media campaigns to change health behaviour</article-title>. <source>Lancet (London, England)</source>. (<year>2010</year>) <volume>376</volume>(<issue>9748</issue>):<fpage>1261</fpage>&#x2013;<lpage>71</lpage>. <pub-id pub-id-type="doi">10.1016/S0140-6736(10)60809-4</pub-id><pub-id pub-id-type="pmid">20933263</pub-id></citation></ref>
<ref id="B62"><label>62.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Castillo</surname><given-names>EG</given-names></name><name><surname>Ijadi-Maghsoodi</surname><given-names>R</given-names></name><name><surname>Shadravan</surname><given-names>S</given-names></name><name><surname>Moore</surname><given-names>E</given-names></name><name><surname>Menash</surname><given-names>OM</given-names><suffix>III</suffix></name><name><surname>Docherty</surname><given-names>M</given-names></name><etal/></person-group> <article-title>Community interventions to promote mental health and social equity</article-title>. <source>Focus</source> (<year>2020</year>) <volume>18</volume>(<issue>1</issue>):<fpage>60</fpage>&#x2013;<lpage>70</lpage>. <pub-id pub-id-type="doi">10.1176/appi.focus.18102</pub-id><pub-id pub-id-type="pmid">32015729</pub-id></citation></ref>
<ref id="B63"><label>63.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Seymour</surname><given-names>J</given-names></name></person-group>. <article-title>The impact of public health awareness campaigns on the awareness and quality of palliative care</article-title>. <source>J Palliat Med</source>. (<year>2018</year>) <volume>21</volume>(<issue>S1</issue>):<fpage>S30</fpage>&#x2013;<lpage>6</lpage>. <pub-id pub-id-type="doi">10.1089/jpm.2017.0391</pub-id><pub-id pub-id-type="pmid">29283867</pub-id></citation></ref>
<ref id="B64"><label>64.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Patil</surname><given-names>AD</given-names></name><name><surname>Vaidya</surname><given-names>RA</given-names></name><name><surname>Begum</surname><given-names>S</given-names></name><name><surname>Chauhan</surname><given-names>SL</given-names></name><name><surname>Mukherjee</surname><given-names>S</given-names></name><name><surname>Kokate</surname><given-names>PP</given-names></name><etal/></person-group> <article-title>An integrated multidisciplinary model of care for addressing comorbidities beyond reproductive health among women with polycystic ovary syndrome in India</article-title>. <source>Indian J Med Res</source>. (<year>2022</year>) <volume>156</volume>(<issue>3</issue>):<fpage>449</fpage>&#x2013;<lpage>58</lpage>. <pub-id pub-id-type="doi">10.4103/ijmr.IJMR_2497_19</pub-id><pub-id pub-id-type="pmid">36588359</pub-id></citation></ref>
<ref id="B65"><label>65.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Kumar</surname><given-names>N</given-names></name><name><surname>Raghunathan</surname><given-names>K</given-names></name><name><surname>Quisumbing</surname><given-names>A</given-names></name><name><surname>Scott</surname><given-names>S</given-names></name><name><surname>Menon</surname><given-names>P</given-names></name><name><surname>Thai</surname><given-names>G</given-names></name><etal/></person-group> <article-title>Women improving nutrition through self-help groups in India: does nutrition information help?</article-title> <source>Food Policy</source>. (<year>2024</year>) <volume>128</volume>:<fpage>102716</fpage>. <pub-id pub-id-type="doi">10.1016/j.foodpol.2024.102716</pub-id><pub-id pub-id-type="pmid">39507583</pub-id></citation></ref>
<ref id="B66"><label>66.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Menezes</surname><given-names>R</given-names></name><name><surname>Lelijveld</surname><given-names>N</given-names></name><name><surname>Wrottesley</surname><given-names>SV</given-names></name><name><surname>Brennan</surname><given-names>E</given-names></name><name><surname>Mates</surname><given-names>E</given-names></name><name><surname>James</surname><given-names>PT</given-names></name></person-group>. <article-title>Integrating women and Girls&#x2019; nutrition services into health systems in low- and middle-income countries: a systematic review</article-title>. <source>Nutrients</source>. (<year>2022</year>) <volume>14</volume>(<issue>21</issue>):<fpage>4488</fpage>. <pub-id pub-id-type="doi">10.3390/nu14214488</pub-id><pub-id pub-id-type="pmid">36364750</pub-id></citation></ref>
<ref id="B67"><label>67.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Hazra</surname><given-names>A</given-names></name><name><surname>Das</surname><given-names>A</given-names></name><name><surname>Ahmad</surname><given-names>J</given-names></name><name><surname>Singh</surname><given-names>S</given-names></name><name><surname>Chaudhuri</surname><given-names>I</given-names></name><name><surname>Purty</surname><given-names>A</given-names></name><etal/></person-group> <article-title>Matching intent with intensity: implementation research on the intensity of health and nutrition programs with women&#x2019;s self-help groups in India</article-title>. <source>Glob Health Sci Pract</source>. (<year>2022</year>) <volume>10</volume>(<issue>2</issue>):<fpage>e37213</fpage>.</citation></ref>
<ref id="B68"><label>68.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Maroju</surname><given-names>RG</given-names></name><name><surname>Choudhari</surname><given-names>SG</given-names></name><name><surname>Shaikh</surname><given-names>MK</given-names></name><name><surname>Borkar</surname><given-names>SK</given-names></name><name><surname>Mendhe</surname><given-names>H</given-names></name></person-group>. <article-title>Role of telemedicine and digital technology in public health in India: a narrative review</article-title>. <source>Cureus</source>. (<year>2023</year>) <volume>15</volume>(<issue>3</issue>):<fpage>1</fpage>&#x2013;<lpage>12</lpage>.</citation></ref>
<ref id="B69"><label>69.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Sydora</surname><given-names>BC</given-names></name><name><surname>Wilke</surname><given-names>MS</given-names></name><name><surname>McPherson</surname><given-names>M</given-names></name><name><surname>Chambers</surname><given-names>S</given-names></name><name><surname>Ghosh</surname><given-names>M</given-names></name><name><surname>Vine</surname><given-names>DF</given-names></name></person-group>. <article-title>Challenges in diagnosis and health care in polycystic ovary syndrome in Canada: a patient view to improve health care</article-title>. <source>BMC Women&#x2019;s Health</source>. (<year>2023</year>) <volume>23</volume>(<issue>1</issue>):<fpage>1</fpage>&#x2013;<lpage>13</lpage>. <pub-id pub-id-type="doi">10.1186/s12905-023-02732-2</pub-id></citation></ref>
<ref id="B70"><label>70.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Joshi</surname><given-names>R</given-names></name><name><surname>Alim</surname><given-names>M</given-names></name><name><surname>Kengne</surname><given-names>AP</given-names></name><name><surname>Jan</surname><given-names>S</given-names></name><name><surname>Maulik</surname><given-names>PK</given-names></name><name><surname>Peiris</surname><given-names>D</given-names></name><etal/></person-group> <article-title>Task shifting for non-communicable disease management in low and middle income countries&#x2014;a systematic review</article-title>. <source>PLoS One</source>. (<year>2014</year>) <volume>9</volume>(<issue>8</issue>):<fpage>e103754</fpage>. <pub-id pub-id-type="doi">10.1371/journal.pone.0103754</pub-id><pub-id pub-id-type="pmid">25121789</pub-id></citation></ref>
<ref id="B71"><label>71.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Tesema</surname><given-names>AG</given-names></name><name><surname>Mabunda</surname><given-names>SA</given-names></name><name><surname>Chaudhri</surname><given-names>K</given-names></name><name><surname>Sunjaya</surname><given-names>A</given-names></name><name><surname>Thio</surname><given-names>S</given-names></name><name><surname>Yakubu</surname><given-names>K</given-names></name><etal/></person-group> <article-title>Task-sharing for non-communicable disease prevention and control in low- and middle-income countries in the context of health worker shortages: a systematic review</article-title>. <source>PLOS Glob Public Heal</source>. (<year>2025</year>) <volume>5</volume>(<issue>4</issue>):<fpage>e0004289</fpage>. <comment>Available online at:</comment> <ext-link ext-link-type="uri" xlink:href="https://pmc.ncbi.nlm.nih.gov/articles/PMC12002516/">https://pmc.ncbi.nlm.nih.gov/articles/PMC12002516/</ext-link></citation></ref>
<ref id="B72"><label>72.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Hartzler</surname><given-names>AL</given-names></name><name><surname>Tuzzio</surname><given-names>L</given-names></name><name><surname>Hsu</surname><given-names>C</given-names></name><name><surname>Wagner</surname><given-names>EH</given-names></name></person-group>. <article-title>Roles and functions of community health workers in primary care</article-title>. <source>Ann Fam Med</source>. (<year>2018</year>) <volume>16</volume>(<issue>3</issue>):<fpage>240</fpage>&#x2013;<lpage>5</lpage>. <pub-id pub-id-type="doi">10.1370/afm.2208</pub-id><pub-id pub-id-type="pmid">29760028</pub-id></citation></ref>
<ref id="B73"><label>73.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Grave</surname><given-names>RD</given-names></name><name><surname>Calugi</surname><given-names>S</given-names></name><name><surname>Centis</surname><given-names>E</given-names></name><name><surname>Marzocchi</surname><given-names>R</given-names></name><name><surname>El Ghoch</surname><given-names>M</given-names></name><name><surname>Marchesini</surname><given-names>G</given-names></name></person-group>. <article-title>Lifestyle modification in the management of the metabolic syndrome: achievements and challenges</article-title>. <source>Diabetes Metab Syndr Obes</source>. (<year>2010</year>) <volume>3</volume>:<fpage>373</fpage>&#x2013;<lpage>85</lpage>. <pub-id pub-id-type="doi">10.2147/DMSO.S13860</pub-id><pub-id pub-id-type="pmid">21437107</pub-id></citation></ref>
<ref id="B74"><label>74.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>P&#x00E9;rez-Jover</surname><given-names>V</given-names></name><name><surname>Sala-Gonz&#x00E1;lez</surname><given-names>M</given-names></name><name><surname>Guilabert</surname><given-names>M</given-names></name><name><surname>Mira</surname><given-names>JJ</given-names></name></person-group>. <article-title>Mobile apps for increasing treatment adherence: systematic review</article-title>. <source>J Med Internet Res</source>. (<year>2019</year>) <volume>21</volume>(<issue>6</issue>):<fpage>e12505</fpage>. <pub-id pub-id-type="doi">10.2196/12505</pub-id></citation></ref>
<ref id="B75"><label>75.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Redfern</surname><given-names>J</given-names></name><name><surname>Coorey</surname><given-names>G</given-names></name><name><surname>Mulley</surname><given-names>J</given-names></name><name><surname>Scaria</surname><given-names>A</given-names></name><name><surname>Neubeck</surname><given-names>L</given-names></name><name><surname>Hafiz</surname><given-names>N</given-names></name><etal/></person-group> <article-title>A digital health intervention for cardiovascular disease management in primary care (CONNECT) randomized controlled trial</article-title>. <source>npj Digit Med</source>. (<year>2020</year>) <volume>3</volume>(<issue>1</issue>):<fpage>1</fpage>&#x2013;<lpage>9</lpage>. <pub-id pub-id-type="doi">10.1038/s41746-020-00325-z</pub-id><pub-id pub-id-type="pmid">31934645</pub-id></citation></ref>
<ref id="B76"><label>76.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Malhotra</surname><given-names>K</given-names></name><name><surname>Pan</surname><given-names>CSC</given-names></name><name><surname>Davitadze</surname><given-names>M</given-names></name><name><surname>Kempegowda</surname><given-names>P</given-names></name></person-group>. <article-title>Identifying the challenges and opportunities of PCOS awareness month by analysing its global digital impact</article-title>. <source>Front Endocrinol (Lausanne)</source>. (<year>2023</year>) <volume>14</volume>:<fpage>1109141</fpage>. <pub-id pub-id-type="doi">10.3389/fendo.2023.1109141</pub-id><pub-id pub-id-type="pmid">36936163</pub-id></citation></ref>
<ref id="B77"><label>77.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Torres-Zegarra</surname><given-names>C</given-names></name><name><surname>Sundararajan</surname><given-names>D</given-names></name><name><surname>Benson</surname><given-names>J</given-names></name><name><surname>Seagle</surname><given-names>H</given-names></name><name><surname>Witten</surname><given-names>M</given-names></name><name><surname>Walders-Abramson</surname><given-names>N</given-names></name><etal/></person-group> <article-title>Care for adolescents with PCOS: development and prescribing patterns of a multidisciplinary clinic</article-title>. <source>J Pediatr Adolesc Gynecol</source>. (<year>2021</year>) <volume>34</volume>(<issue>5</issue>):<fpage>617</fpage>&#x2013;<lpage>25</lpage>. <pub-id pub-id-type="doi">10.1016/j.jpag.2021.02.002</pub-id><pub-id pub-id-type="pmid">33794340</pub-id></citation></ref>
<ref id="B78"><label>78.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Parasuraman</surname><given-names>G</given-names></name><name><surname>Jeemon</surname><given-names>P</given-names></name><name><surname>Thankappan</surname><given-names>KR</given-names></name><name><surname>Ali</surname><given-names>MK</given-names></name><name><surname>Mahal</surname><given-names>A</given-names></name><name><surname>McPake</surname><given-names>B</given-names></name><etal/></person-group> <article-title>Community control of hypertension and diabetes (CoCo-HD) program in the Indian states of kerala and tamil nadu: a study protocol for a type 3 hybrid trial</article-title>. <source>BMC Public Health</source>. (<year>2024</year>) <volume>24</volume>(<issue>1</issue>):<fpage>2275</fpage>. <pub-id pub-id-type="doi">10.1186/s12889-024-19746-6</pub-id><pub-id pub-id-type="pmid">39169312</pub-id></citation></ref>
<ref id="B79"><label>79.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Asweto</surname><given-names>CO</given-names></name><name><surname>Alzain</surname><given-names>MA</given-names></name><name><surname>Andrea</surname><given-names>S</given-names></name><name><surname>Alexander</surname><given-names>R</given-names></name><name><surname>Wang</surname><given-names>W</given-names></name></person-group>. <article-title>Integration of community health workers into health systems in developing countries: opportunities and challenges</article-title>. <source>Fam Med Community Heal</source>. (<year>2016</year>) <volume>4</volume>(<issue>1</issue>):<fpage>37</fpage>&#x2013;<lpage>45</lpage>. <pub-id pub-id-type="doi">10.15212/FMCH.2016.0102</pub-id></citation></ref>
<ref id="B80"><label>80.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Hirschhorn</surname><given-names>LR</given-names></name><name><surname>Govender</surname><given-names>I</given-names></name><name><surname>Zulu</surname><given-names>JM</given-names></name></person-group>. <article-title>Community health workers: essential in ensuring primary health care for equitable universal health coverage, but more knowledge and action is needed</article-title>. <source>BMC Prim Care</source>. (<year>2023</year>) <volume>24</volume>(<issue>1</issue>):<fpage>1</fpage>&#x2013;<lpage>2</lpage>. <pub-id pub-id-type="doi">10.1186/s12875-023-02175-6</pub-id><pub-id pub-id-type="pmid">36588155</pub-id></citation></ref>
<ref id="B81"><label>81.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Tripathi</surname><given-names>N</given-names></name><name><surname>Parhad</surname><given-names>P</given-names></name><name><surname>Garg</surname><given-names>S</given-names></name><name><surname>Biswal</surname><given-names>SS</given-names></name><name><surname>Ramasamy</surname><given-names>S</given-names></name><name><surname>Panda</surname><given-names>A</given-names></name><etal/></person-group> <article-title>Performance of health and wellness centre in providing primary care services in Chhattisgarh, India</article-title>. <source>BMC Prim Care</source>. (<year>2024</year>) <volume>25</volume>(<issue>1</issue>):<fpage>360</fpage>. <pub-id pub-id-type="doi">10.1186/s12875-024-02603-1</pub-id><pub-id pub-id-type="pmid">39367295</pub-id></citation></ref>
<ref id="B82"><label>82.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Brar</surname><given-names>S</given-names></name><name><surname>Purohit</surname><given-names>N</given-names></name><name><surname>Prinja</surname><given-names>S</given-names></name><name><surname>Singh</surname><given-names>G</given-names></name><name><surname>Bahuguna</surname><given-names>P</given-names></name><name><surname>Kaur</surname><given-names>M</given-names></name></person-group>. <article-title>What and how much do the community health officers and auxiliary nurse midwives do in health and wellness centres in a block in Punjab? A time-motion study</article-title>. <source>Indian J Public Health</source>. (<year>2021</year>) <volume>65</volume>(<issue>3</issue>):<fpage>275</fpage>&#x2013;<lpage>9</lpage>. <pub-id pub-id-type="doi">10.4103/ijph.IJPH_1489_20</pub-id><pub-id pub-id-type="pmid">34558490</pub-id></citation></ref>
<ref id="B83"><label>83.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Paier-Abuzahra</surname><given-names>M</given-names></name><name><surname>Posch</surname><given-names>N</given-names></name><name><surname>Jeitler</surname><given-names>K</given-names></name><name><surname>Semlitsch</surname><given-names>T</given-names></name><name><surname>Radl-Karimi</surname><given-names>C</given-names></name><name><surname>Spary-Kainz</surname><given-names>U</given-names></name><etal/></person-group> <article-title>Effects of task-shifting from primary care physicians to nurses: an overview of systematic reviews</article-title>. <source>Hum Resour Health</source>. (<year>2024</year>) <volume>22</volume>(<issue>1</issue>):<fpage>1</fpage>&#x2013;<lpage>14</lpage>. <pub-id pub-id-type="doi">10.1186/s12960-024-00956-3</pub-id><pub-id pub-id-type="pmid">38167317</pub-id></citation></ref>
<ref id="B84"><label>84.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Mbaruku</surname><given-names>G</given-names></name><name><surname>Bergstr&#x00F6;m</surname><given-names>S</given-names></name></person-group>. <article-title>Reducing maternal mortality in Kigoma, Tanzania</article-title>. <source>Health Policy Plan</source>. (<year>1995</year>) <volume>10</volume>(<issue>1</issue>):<fpage>71</fpage>&#x2013;<lpage>8</lpage>. <pub-id pub-id-type="doi">10.1093/heapol/10.1.71</pub-id><pub-id pub-id-type="pmid">10141624</pub-id></citation></ref>
<ref id="B85"><label>85.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Dzudie</surname><given-names>A</given-names></name><name><surname>Kengne</surname><given-names>AP</given-names></name><name><surname>Muna</surname><given-names>WFT</given-names></name><name><surname>Ba</surname><given-names>H</given-names></name><name><surname>Menanga</surname><given-names>A</given-names></name><name><surname>Kouam</surname><given-names>CK</given-names></name><etal/></person-group> <article-title>Prevalence, awareness, treatment and control of hypertension in a self-selected Sub-Saharan African urban population: a cross-sectional study</article-title>. <source>BMJ Open</source>. (<year>2012</year>) <volume>2</volume>(<issue>4</issue>):<fpage>e001217</fpage>. <pub-id pub-id-type="doi">10.1136/bmjopen-2012-001217</pub-id><pub-id pub-id-type="pmid">22923629</pub-id></citation></ref>
<ref id="B86"><label>86.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Zhu</surname><given-names>M</given-names></name><name><surname>Wang</surname><given-names>K</given-names></name><name><surname>Feng</surname><given-names>J</given-names></name><name><surname>Liu</surname><given-names>Y</given-names></name><name><surname>Guan</surname><given-names>M</given-names></name><name><surname>Wang</surname><given-names>Y</given-names></name><etal/></person-group> <article-title>The waist-to-height ratio is a good predictor for insulin resistance in women with polycystic ovary syndrome</article-title>. <source>Front Endocrinol (Lausanne)</source>. (<year>2024</year>) <volume>15</volume>:<fpage>1502321</fpage>. <pub-id pub-id-type="doi">10.3389/fendo.2024.1502321</pub-id><pub-id pub-id-type="pmid">39717101</pub-id></citation></ref>
<ref id="B87"><label>87.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Arora</surname><given-names>S</given-names></name><name><surname>Huda</surname><given-names>RK</given-names></name><name><surname>Verma</surname><given-names>S</given-names></name><name><surname>Khetan</surname><given-names>M</given-names></name><name><surname>Sangwan</surname><given-names>RK</given-names></name></person-group>. <article-title>Challenges, barriers, and facilitators in telemedicine implementation in India: a scoping review</article-title>. <source>Cureus</source>. (<year>2024</year>) <volume>16</volume>(<issue>8</issue>):<fpage>e67388</fpage>. <pub-id pub-id-type="doi">10.7759/cureus.67388</pub-id><pub-id pub-id-type="pmid">39310647</pub-id></citation></ref>
<ref id="B88"><label>88.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Shende</surname><given-names>V</given-names></name><name><surname>Wagh</surname><given-names>V</given-names></name></person-group>. <article-title>Role of telemedicine and telehealth in public healthcare sector: a narrative review</article-title>. <source>Cureus</source>. (<year>2024</year>) <volume>16</volume>(<issue>9</issue>):<fpage>e69102</fpage>. <pub-id pub-id-type="doi">10.7759/cureus.69102</pub-id><pub-id pub-id-type="pmid">39391420</pub-id></citation></ref>
<ref id="B89"><label>89.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Wells</surname><given-names>S</given-names></name><name><surname>Riddell</surname><given-names>T</given-names></name><name><surname>Kerr</surname><given-names>A</given-names></name><name><surname>Pylypchuk</surname><given-names>R</given-names></name><name><surname>Chelimo</surname><given-names>C</given-names></name><name><surname>Marshall</surname><given-names>R</given-names></name><etal/></person-group> <article-title>Cohort profile: the PREDICT cardiovascular disease cohort in New Zealand primary care (PREDICT-CVD 19)</article-title>. <source>Int J Epidemiol</source>. (<year>2017</year>) <volume>46</volume>(<issue>1</issue>):<fpage>22</fpage>. <pub-id pub-id-type="doi">10.1093/ije/dyv312</pub-id><pub-id pub-id-type="pmid">26686841</pub-id></citation></ref>
<ref id="B90"><label>90.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Aranda-Jan</surname><given-names>CB</given-names></name><name><surname>Mohutsiwa-Dibe</surname><given-names>N</given-names></name><name><surname>Loukanova</surname><given-names>S</given-names></name></person-group>. <article-title>Systematic review on what works, what does not work and why of implementation of mobile health (mHealth) projects in Africa</article-title>. <source>BMC Public Health</source>. (<year>2014</year>) <volume>14</volume>(<issue>1</issue>):<fpage>1</fpage>&#x2013;<lpage>15</lpage>. <pub-id pub-id-type="doi">10.1186/1471-2458-14-188</pub-id><pub-id pub-id-type="pmid">24383435</pub-id></citation></ref>
<ref id="B91"><label>91.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Parameshwarappa</surname><given-names>PM</given-names></name><name><surname>Olickal</surname><given-names>JJ</given-names></name></person-group>. <article-title>Telemedicine awareness and the preferred digital healthcare tools: a community-based cross-sectional study from rural Karnataka, India</article-title>. <source>Indian J Community Med</source>. (<year>2023</year>) <volume>48</volume>(<issue>6</issue>):<fpage>915</fpage>&#x2013;<lpage>9</lpage>. <pub-id pub-id-type="doi">10.4103/ijcm.ijcm_770_22</pub-id><pub-id pub-id-type="pmid">38249713</pub-id></citation></ref>
<ref id="B92"><label>92.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Dastidar</surname><given-names>BG</given-names></name><name><surname>Jani</surname><given-names>AR</given-names></name><name><surname>Suri</surname><given-names>S</given-names></name><name><surname>Nagaraja</surname><given-names>VH</given-names></name></person-group>. <article-title>Reimagining India&#x2019;s national telemedicine service to improve access to care</article-title>. <source>Lancet Reg Heal Southeast Asia</source>. (<year>2024</year>) <volume>30</volume>:<fpage>100480</fpage>. <pub-id pub-id-type="doi">10.1016/j.lansea.2024.100480</pub-id></citation></ref>
<ref id="B93"><label>93.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Borges do Nascimento</surname><given-names>IJ</given-names></name><name><surname>Abdulazeem</surname><given-names>H</given-names></name><name><surname>Vasanthan</surname><given-names>LT</given-names></name><name><surname>Martinez</surname><given-names>EZ</given-names></name><name><surname>Zucoloto</surname><given-names>ML</given-names></name><name><surname>&#x00D8;stengaard</surname><given-names>L</given-names></name><etal/></person-group> <article-title>Barriers and facilitators to utilizing digital health technologies by healthcare professionals</article-title>. <source>NPJ Digit Med</source>. (<year>2023</year>) <volume>6</volume>(<issue>1</issue>):<fpage>1</fpage>&#x2013;<lpage>28</lpage>. <pub-id pub-id-type="doi">10.1038/s41746-023-00899-4</pub-id><pub-id pub-id-type="pmid">36596833</pub-id></citation></ref>
<ref id="B94"><label>94.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Alotaibi</surname><given-names>M</given-names></name><name><surname>Ali Shaman</surname><given-names>A</given-names></name></person-group>. <article-title>Enhancing polycystic ovarian syndrome awareness using private social network</article-title>. <source>mHealth</source>. (<year>2020</year>) <volume>6</volume>:<fpage>1</fpage>&#x2013;<lpage>7</lpage>. <comment>Available online at:</comment> <ext-link ext-link-type="uri" xlink:href="https://pubmed.ncbi.nlm.nih.gov/33209914/">https://pubmed.ncbi.nlm.nih.gov/33209914/</ext-link><pub-id pub-id-type="pmid">32190612</pub-id></citation></ref>
<ref id="B95"><label>95.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Kohli</surname><given-names>C</given-names></name><name><surname>Kishore</surname><given-names>J</given-names></name><name><surname>Sharma</surname><given-names>S</given-names></name><name><surname>Nayak</surname><given-names>H</given-names></name></person-group>. <article-title>Knowledge and practice of accredited social health activists for maternal healthcare delivery in Delhi</article-title>. <source>J Fam Med Prim Care</source>. (<year>2015</year>) <volume>4</volume>(<issue>3</issue>):<fpage>359</fpage>. <pub-id pub-id-type="doi">10.4103/2249-4863.161317</pub-id></citation></ref>
<ref id="B96"><label>96.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Nandan</surname><given-names>D</given-names></name><name><surname>Agarwal</surname><given-names>D</given-names></name></person-group>. <article-title>Human resources for health in India: urgent need for reforms</article-title>. <source>Indian J Community Med</source>. (<year>2012</year>) <volume>37</volume>(<issue>4</issue>):<fpage>205</fpage>&#x2013;<lpage>6</lpage>. <pub-id pub-id-type="doi">10.4103/0970-0218.103464</pub-id><pub-id pub-id-type="pmid">23293430</pub-id></citation></ref>
<ref id="B97"><label>97.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Jones</surname><given-names>H</given-names></name><name><surname>Sprung</surname><given-names>VS</given-names></name><name><surname>Pugh</surname><given-names>CJA</given-names></name><name><surname>Daousi</surname><given-names>C</given-names></name><name><surname>Irwin</surname><given-names>A</given-names></name><name><surname>Aziz</surname><given-names>N</given-names></name><etal/></person-group> <article-title>Polycystic ovary syndrome with hyperandrogenism is characterized by an increased risk of hepatic steatosis compared to nonhyperandrogenic PCOS phenotypes and healthy controls, independent of obesity and insulin resistance</article-title>. <source>J Clin Endocrinol Metab</source>. (<year>2012</year>) <volume>97</volume>(<issue>10</issue>):<fpage>3709</fpage>&#x2013;<lpage>16</lpage>. <pub-id pub-id-type="doi">10.1210/jc.2012-1382</pub-id><pub-id pub-id-type="pmid">22837189</pub-id></citation></ref>
<ref id="B98"><label>98.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Labhardt</surname><given-names>ND</given-names></name><name><surname>Balo</surname><given-names>JR</given-names></name><name><surname>Ndam</surname><given-names>M</given-names></name><name><surname>Grimm</surname><given-names>JJ</given-names></name><name><surname>Manga</surname><given-names>E</given-names></name></person-group>. <article-title>Task shifting to non-physician clinicians for integrated management of hypertension and diabetes in rural Cameroon: a programme assessment at two years</article-title>. <source>BMC Health Serv Res</source>. (<year>2010</year>) <volume>10</volume>:<fpage>1</fpage>&#x2013;<lpage>9</lpage>. <pub-id pub-id-type="doi">10.1186/1472-6963-10-339</pub-id><pub-id pub-id-type="pmid">20044945</pub-id></citation></ref>
<ref id="B99"><label>99.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Fairall</surname><given-names>L</given-names></name><name><surname>Bachmann</surname><given-names>MO</given-names></name><name><surname>Lombard</surname><given-names>C</given-names></name><name><surname>Timmerman</surname><given-names>V</given-names></name><name><surname>Uebel</surname><given-names>K</given-names></name><name><surname>Zwarenstein</surname><given-names>M</given-names></name><etal/></person-group> <article-title>Task shifting of antiretroviral treatment from doctors to primary-care nurses in South Africa (STRETCH): a pragmatic, parallel, cluster-randomised trial</article-title>. <source>Lancet</source>. (<year>2012</year>) <volume>380</volume>(<issue>9845</issue>):<fpage>889</fpage>. <pub-id pub-id-type="doi">10.1016/S0140-6736(12)60730-2</pub-id><pub-id pub-id-type="pmid">22901955</pub-id></citation></ref>
<ref id="B100"><label>100.</label><citation citation-type="other"><collab>American Society for Reproductive Medicine &#x007C; ASRM</collab>. <article-title>Recommendations from the 2023 International Evidence-based Guideline for the Assessment and Management of Polycystic Ovary Syndrome (2023)&#x2014;practice guidance</article-title> (<year>2023</year>). <comment>Available online at:</comment> <ext-link ext-link-type="uri" xlink:href="https://www.asrm.org/practice-guidance/practice-committee-documents/recommendations-from-the-2023-international-evidence-based-guideline-for-the-assessment-and-management-of-polycystic-ovary-syndrome/">https://www.asrm.org/practice-guidance/practice-committee-documents/recommendations-from-the-2023-international-evidence-based-guideline-for-the-assessment-and-management-of-polycystic-ovary-syndrome/</ext-link> <comment>(Accessed February 11, 2025)</comment>.</citation></ref>
<ref id="B101"><label>101.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Misso</surname><given-names>M</given-names></name><name><surname>Costello</surname><given-names>M</given-names></name><name><surname>Dokras</surname><given-names>A</given-names></name><name><surname>Laven</surname><given-names>J</given-names></name><name><surname>Moran</surname><given-names>L</given-names></name><name><surname>Piltonen</surname><given-names>T</given-names></name><etal/></person-group> <article-title>Under section 14A of the national health and medical research council act</article-title>. <source>Natl Heal Med Res Counc</source>. (<year>2018</year>) <volume>2</volume>.</citation></ref>
<ref id="B102"><label>102.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Barasa</surname><given-names>E</given-names></name><name><surname>Rogo</surname><given-names>K</given-names></name><name><surname>Mwaura</surname><given-names>N</given-names></name><name><surname>Chuma</surname><given-names>J</given-names></name></person-group>. <article-title>Kenya National hospital insurance fund reforms: implications and lessons for universal health coverage</article-title>. <source>Heal Syst Reform</source>. (<year>2018</year>) <volume>4</volume>(<issue>4</issue>):<fpage>346</fpage>&#x2013;<lpage>61</lpage>. <pub-id pub-id-type="doi">10.1080/23288604.2018.1513267</pub-id></citation></ref>
<ref id="B103"><label>103.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Ramani</surname><given-names>VK</given-names></name><name><surname>Suresh</surname><given-names>K</given-names></name></person-group>. <article-title>Prevalence of hypertension and diabetes morbidity among adults in a few urban slums of bangalore city, determinants of its risk factors and opportunities for control&#x2014;a cross-sectional study</article-title>. <source>J Fam Med Prim Care</source>. (<year>2020</year>) <volume>9</volume>(<issue>7</issue>):<fpage>3264</fpage>. <pub-id pub-id-type="doi">10.4103/jfmpc.jfmpc_234_20</pub-id></citation></ref>
<ref id="B104"><label>104.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Malhotra</surname><given-names>S</given-names></name><name><surname>Shah</surname><given-names>R</given-names></name></person-group>. <article-title>Women and mental health in India: an overview</article-title>. <source>Indian J Psychiatry</source>. (<year>2015</year>) <volume>57</volume>(<issue>Suppl 2</issue>):<fpage>205</fpage>&#x2013;<lpage>11</lpage>. <pub-id pub-id-type="doi">10.4103/0019-5545.161479</pub-id><pub-id pub-id-type="pmid">26124530</pub-id></citation></ref>
<ref id="B105"><label>105.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Latha</surname><given-names>K</given-names></name><name><surname>Meena</surname><given-names>KS</given-names></name><name><surname>Pravitha</surname><given-names>MR</given-names></name><name><surname>Dasgupta</surname><given-names>M</given-names></name><name><surname>Chaturvedi</surname><given-names>SK</given-names></name></person-group>. <article-title>Effective use of social media platforms for promotion of mental health awareness</article-title>. <source>J Educ Health Promot</source>. (<year>2020</year>) <volume>9</volume>(<issue>1</issue>):<fpage>124</fpage>&#x2013;<lpage>124</lpage>. <pub-id pub-id-type="doi">10.4103/jehp.jehp_90_20</pub-id><pub-id pub-id-type="pmid">32642480</pub-id></citation></ref>
<ref id="B106"><label>106.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Ganie</surname><given-names>M</given-names></name><name><surname>Vasudevan</surname><given-names>V</given-names></name><name><surname>Wani</surname><given-names>I</given-names></name><name><surname>Baba</surname><given-names>M</given-names></name><name><surname>Arif</surname><given-names>T</given-names></name><name><surname>Rashid</surname><given-names>A</given-names></name></person-group>. <article-title>Epidemiology, pathogenesis, genetics &#x0026; management of polycystic ovary syndrome in India</article-title>. <source>Indian J Med Res</source>. (<year>2019</year>) <volume>150</volume>(<issue>4</issue>):<fpage>333</fpage>&#x2013;<lpage>44</lpage>. <pub-id pub-id-type="doi">10.4103/ijmr.IJMR_1937_17</pub-id><pub-id pub-id-type="pmid">31823915</pub-id></citation></ref>
<ref id="B107"><label>107.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Joshi</surname><given-names>A</given-names></name></person-group>. <article-title>PCOS Stratification for precision diagnostics and treatment</article-title>. <source>Front Cell Dev Biol</source>. (<year>2024</year>) <volume>12</volume>:<fpage>1358755</fpage>. <pub-id pub-id-type="doi">10.3389/fcell.2024.1358755</pub-id><pub-id pub-id-type="pmid">38389707</pub-id></citation></ref>
<ref id="B108"><label>108.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Kepper</surname><given-names>MM</given-names></name><name><surname>Stamatakis</surname><given-names>KA</given-names></name><name><surname>Deitch</surname><given-names>A</given-names></name><name><surname>Terhaar</surname><given-names>A</given-names></name><name><surname>Gates</surname><given-names>E</given-names></name><name><surname>Cole</surname><given-names>G</given-names></name><etal/></person-group> <article-title>Sustainability planning for a community network to increase participation in evidence-based lifestyle change programs: a mixed-methods approach</article-title>. <source>Int J Environ Res Public Health</source>. (<year>2024</year>) <volume>21</volume>(<issue>4</issue>):<fpage>463</fpage>. <pub-id pub-id-type="doi">10.3390/ijerph21040463</pub-id><pub-id pub-id-type="pmid">38673374</pub-id></citation></ref>
<ref id="B109"><label>109.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Li</surname><given-names>M</given-names></name><name><surname>He</surname><given-names>Z</given-names></name><name><surname>Shi</surname><given-names>L</given-names></name><name><surname>Lin</surname><given-names>M</given-names></name><name><surname>Li</surname><given-names>M</given-names></name><name><surname>Cheng</surname><given-names>Y</given-names></name><etal/></person-group> <article-title>Intelligent detection for polycystic ovary syndrome (PCOS): taxonomy, datasets and detection tools</article-title>. <source>Comput Struct Biotechnol J</source>. (<year>2025</year>) <volume>27</volume>:<fpage>1578</fpage>. <comment>Available online at:</comment> <ext-link ext-link-type="uri" xlink:href="https://pmc.ncbi.nlm.nih.gov/articles/PMC12032871/">https://pmc.ncbi.nlm.nih.gov/articles/PMC12032871/</ext-link><pub-id pub-id-type="pmid">40291542</pub-id></citation></ref>
<ref id="B110"><label>110.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Piorino</surname><given-names>F</given-names></name><name><surname>Patterson</surname><given-names>AT</given-names></name><name><surname>Styczynski</surname><given-names>MP</given-names></name></person-group>. <article-title>Low-cost, point-of-care biomarker quantification</article-title>. <source>Curr Opin Biotechnol</source>. (<year>2022</year>) <volume>76</volume>:<fpage>102738</fpage>. <pub-id pub-id-type="doi">10.1016/j.copbio.2022.102738</pub-id><pub-id pub-id-type="pmid">35679813</pub-id></citation></ref>
<ref id="B111"><label>111.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Sudharsan</surname><given-names>V</given-names></name><name><surname>Davidson</surname><given-names>PD</given-names></name><name><surname>Lakshmi</surname><given-names>KV</given-names></name><name><surname>Amudha</surname><given-names>VP</given-names></name><name><surname>Rani</surname><given-names>MRH</given-names></name></person-group>. <article-title>Development and validation of a screening tool for the identification of refractive errors among school going children in tamil nadu</article-title>. <source>India. Natl J Community Med</source>. (<year>2023</year>) <volume>14</volume>(<issue>9</issue>):<fpage>581</fpage>&#x2013;<lpage>7</lpage>. <pub-id pub-id-type="doi">10.55489/njcm.140920232751</pub-id></citation></ref>
<ref id="B112"><label>112.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Coppini</surname><given-names>G</given-names></name><name><surname>Colantonio</surname><given-names>S</given-names></name></person-group>. <article-title>Self-monitoring systems for personalised health-care and lifestyle surveillance</article-title>. <source>Comput Biol Med</source>. (<year>2017</year>) <volume>88</volume>(<issue>July</issue>):<fpage>161</fpage>&#x2013;<lpage>2</lpage>. <pub-id pub-id-type="doi">10.1016/j.compbiomed.2017.07.011</pub-id><pub-id pub-id-type="pmid">28735153</pub-id></citation></ref></ref-list>
</back>
</article>